10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

 

Commission file number 000-56132

GREEN THUMB INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

British Columbia	98-1437430
(State or other jurisdiction of incorporation or organization)	(I.R.S. employer identification no.)
325 West Huron Street, Suite 700 Chicago, Illinois	60654
(Address of principal executive offices)	(zip code)

Registrant’s telephone number, including area code - (312) 471-6720

Securities registered pursuant to Section 12(g) of the Act:

Subordinate Voting Shares

Multiple Voting Shares

Super Voting Shares

(Title of each Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 day. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of November 1, 2023, there were 210,095,615 of the registrant’s Subordinate Voting Shares, 38,531 of the registrant’s Multiple Voting Shares and 226,690 of the registrant’s Super Voting Shares outstanding.

GREEN THUMB INDUSTRIES INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED September 30, 2023

TABLE OF CONTENTS

FINANCIAL INFORMATION		Page
	Part I
ITEM 1:	Unaudited Interim Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022	4
	Unaudited Interim Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022	5
	Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three and nine months ended September 30, 2023 and 2022	6
	Unaudited Interim Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022	8
	Notes to Unaudited Interim Condensed Consolidated Financial Statements	10
ITEM 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
ITEM 3:	Quantitative and Qualitative Disclosure About Market Risk	36
ITEM 4:	Controls and Procedures	36
	Part II
OTHER INFORMATION
ITEM 1:	Legal Proceedings	37
ITEM 1a:	Risk Factors	37
ITEM 2:	Sale of Unregistered Securities	37
ITEM 3:	Defaults Upon Senior Securities	37
ITEM 4:	Mine Safety Disclosure	37
ITEM 5:	Other Information	37
ITEM 6:	Exhibits	38
Signatures		39

Use of Names

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “we,” “us,” “our,” “Company,” “Corporation” or “Green Thumb” refer to Green Thumb Industries Inc. together with its wholly-owned subsidiaries.

Currency

Unless otherwise indicated, all references to “$” or “US$” in this document refer to United States dollars, and all references to “C$” refer to Canadian dollars.

Disclosure Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains statements that we believe are, or may be considered to be, “forward-looking statements.” All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “project,” “anticipate,” “believe,” “plan,” “forecast,” “continue” or “could” or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the “SEC”), and in press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change; the Company may be subject to action by the U.S. federal government; state regulation of cannabis is uncertain; the Company may be subject to heightened scrutiny by Canadian regulatory authorities; the Company may face limitations on ownership of cannabis licenses; the Company may become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco Firearms and Explosives regulation; cannabis businesses are subject to applicable anti-money laundering laws and regulations and have restricted access to banking and other financial services; the Company may face difficulties acquiring additional financing; the Company faces intense competition; the Company faces competition from unregulated products; the Company is dependent upon the popularity and consumer acceptance of its brand portfolio; the Company lacks access to U.S. bankruptcy protections; the Company operates in a highly regulated sector and may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where the Company carries on business; the Company may face difficulties in enforcing its contracts; the Company has limited trademark protection; cannabis businesses are subject to unfavorable tax treatment; cannabis businesses may be subject to civil asset forfeiture; the Company is subject to proceeds of crime statutes; the Company faces exposure to fraudulent or illegal activity; the Company’s use of joint ventures may expose it to risks associated with jointly owned investments; the Company faces risks due to industry immaturity or limited comparable, competitive or established industry best practices; the Company faces risks related to its products; the Company’s business is subject to the risks inherent in agricultural operations; the Company relies on third party software providers for numerous capabilities that it depends upon to operate, and a disruption of one or more systems could adversely affect the business; the Company faces risks related to its information technology systems and potential cyber-attacks and security breaches; the Company faces an inherent risk of product liability or similar claims; the Company’s products may be subject to product recalls; the Company may face unfavorable publicity or consumer perception; the Company’s voting control is concentrated; the Company’s capital structure and voting control may cause unpredictability; and issuances of substantial amounts of Super Voting Shares, Multiple Voting Shares or Subordinate Voting Shares may result in dilution. Further information on these and other potential factors that could affect the Company’s business and financial condition and the results of operations are included in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and elsewhere in the Company’s filings with the SEC, which are available on the SEC’s website or at https://investors.gtigrows.com. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this document, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this document.

3

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Balance Sheets

As of September 30, 2023 and December 31, 2022

(Amounts Expressed in United States Dollars)

	September 30,			December 31,
	2023			2022
				(Audited)
	(in thousands)
ASSETS
Current Assets:
Cash and Cash Equivalents	$	136,842		$	177,682
Accounts Receivable, Net		38,648			30,975
Income Tax Receivable		5,422			7,473
Inventories, Net		118,545			115,675
Prepaid Expenses		14,767			13,364
Other Current Assets		5,957			6,182
Total Current Assets		320,181			351,351
Property and Equipment, Net		692,667			557,873
Right of Use Assets, Net		240,036			242,357
Investments		77,335			74,169
Investments in Associates		25,355			25,508
Intangible Assets, Net		551,422			589,519
Goodwill		589,691			589,691
Deposits and Other Assets		2,525			3,060
TOTAL ASSETS	$	2,499,212		$	2,433,528
LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES
Current Liabilities:
Accounts Payable	$	22,507		$	18,423
Accrued Liabilities		86,469			86,971
Compensation Payable		11,498			13,476
Current Portion of Notes Payable		1,466			1,037
Current Portion of Lease Liabilities		11,818			10,906
Contingent Consideration Payable		—			11,400
Income Tax Payable		16,124			4,358
Total Current Liabilities		149,882			146,571
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion		250,017			249,281
Notes Payable, Net of Current Portion and Debt Discount		297,075			274,631
Contingent Consideration Payable		32,789			30,543
Warrant Liability		—			4,520
Deferred Income Taxes		62,550			62,550
TOTAL LIABILITIES		792,313			768,096
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY
Subordinate Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2023:    Unlimited, 210,042,431, and 210,042,431, respectively, at December 31, 2022:    Unlimited, 206,991,275, and 206,991,275, respectively)		—			—
Multiple Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2023:    Unlimited, 38,531 and 38,531, respectively, at December 31, 2022:    Unlimited, 38,531 and 38,531, respectively)		—			—
Super Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2023:    Unlimited, 226,690 and 226,690, respectively, at December 31, 2022:    Unlimited, 251,690 and 251,690, respectively)		—			—
Share Capital		1,702,344			1,663,557
Contributed Surplus		16,052			23,233
Deferred Share Issuances		12,973			36,211
Accumulated Deficit		(25,034	)		(58,085	)
Equity of Green Thumb Industries Inc.		1,706,335			1,664,916
Noncontrolling interests		564			516
TOTAL SHAREHOLDERS' EQUITY		1,706,899			1,665,432
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	2,499,212		$	2,433,528

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

4

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Operations

Three and Nine Months Ended September 30, 2023 and 2022

(Amounts Expressed in United States Dollars, Except Share Amounts)

		Three Months Ended September 30,								Nine Months Ended September 30,
		2023				2022				2023				2022
		(in thousands)								(in thousands)
Revenues, Net of Discounts	$		275,398		$		261,194		$		776,322		$		758,105
Cost of Goods Sold, Net			(141,592	)			(129,954	)			(392,515	)			(378,127	)
Gross Profit			133,806				131,240				383,807				379,978
Expenses:
Selling, General, and Administrative			84,779				82,479				249,515				214,402
Total Expenses			84,779				82,479				249,515				214,402
Income From Operations			49,027				48,761				134,292				165,576
Other Income (Expense):
Other Income (Expense), Net			(631	)			(2,085	)			23				14,933
Interest Income, Net			1,576				1,085				4,838				2,609
Interest Expense, Net			(4,639	)			(4,644	)			(11,324	)			(16,113	)
Total Other Income (Expense)			(3,694	)			(5,644	)			(6,463	)			1,429
Income Before Provision for Income Taxes And Non-Controlling Interest			45,333				43,117				127,829				167,005
Provision For Income Taxes			34,526				32,969				93,927				102,440
Net Income Before Non-Controlling Interest			10,807				10,148				33,902				64,565
Net Income Attributable to Non-Controlling Interest			295				319				851				1,360
Net Income Attributable To Green Thumb Industries Inc.	$		10,512		$		9,829		$		33,051		$		63,205
Net Income Per Share - Basic	$		0.05		$		0.04		$		0.14		$		0.27
Net Income Per Share - Diluted	$		0.05		$		0.04		$		0.14		$		0.26
Weighted Average Number of Shares Outstanding - Basic			239,459,783				237,002,873				238,248,852				236,546,078
Weighted average Number of Shares Outstanding - Diluted			240,289,959				237,804,799				239,827,112				237,872,595

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

5

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and Nine Months Ended September 30, 2023 and 2022

(Amounts Expressed in United States Dollars)

		Share Capital			Contributed Surplus (Deficit)				Deferred Share Issuance			Accumulated Earnings (Deficit)				Non-Controlling Interest				Total
		(in thousands)
Balance, July 1, 2022	$		1,659,000	$		9,165		$		36,262	$		(16,687	)	$		314		$		1,688,054
Exercise of options and RSUs			1,799			(718	)			—			—				—				1,081
Stock-based compensation			—			7,878				—			—				—				7,878
Distributions to third party and limited liability    company unit holders			—			—				—			—				(354	)			(354	)
Net income			—			—				—			9,829				319				10,148
Balance, September 30, 2022	$		1,660,799	$		16,325		$		36,262	$		(6,858	)	$		279		$		1,706,807
Balance, January 1, 2022	$		1,633,672	$		21,245		$		36,262	$		(70,063	)	$		(1,638	)	$		1,619,478
Noncontrolling interests adjustment for change in ownership			2,379			(17,735	)			—			—				15,356				—
Issuance of shares under business combinations and investments			1,406			—				—			—				—				1,406
Shares issued as contingent consideration			13,111			—				—			—				—				13,111
Exercise of options and RSUs			9,327			(6,643	)			—			—				—				2,684
Stock-based compensation			—			19,362				—			—				—				19,362
Shares issued for settlement of business obligation			904			96				—			—				—				1,000
Distributions to limited liability company unit holders			—			—				—			—				(14,799	)			(14,799	)
Net income			—			—				—			63,205				1,360				64,565
Balance, September 30, 2022	$		1,660,799	$		16,325		$		36,262	$		(6,858	)	$		279		$		1,706,807

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

6

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and Nine Months Ended September 30, 2023 and 2022

(Amounts Expressed in United States Dollars)

		Share Capital			Contributed Surplus (Deficit)				Deferred Share Issuance				Accumulated Earnings (Deficit)				Non-Controlling Interest				Total
		(in thousands)
Balance, July 1, 2023	$		1,693,429	$		34,421		$		12,973		$		(35,546	)	$		539		$		1,705,816
Distribution of Contingent Consideration			6,454			—				—				—				—				6,454
Exercise of options and RSUs			2,461			(694	)			—				—				—				1,767
Stock-based compensation			—			7,215				—				—				—				7,215
Distributions to limited liability company unit holders			—			—				—				—				(270	)			(270	)
Repurchase of Subordinate Voting Shares			—			(24,890	)			—				—				—				(24,890	)
Net income			—			—				—				10,512				295				10,807
Balance, September 30, 2023	$		1,702,344	$		16,052		$		12,973		$		(25,034	)	$		564		$		1,706,899
Balance, January 1, 2023	$		1,663,557	$		23,233		$		36,211		$		(58,085	)	$		516		$		1,665,432
Issuance of deferred shares			20,454			—				(20,454	)			—				—				—
Distribution of contingent consideration			12,524			—				—				—				—				12,524
Indemnification of deferred shares associated with post acquisition costs			—			—				(2,784	)			—				—				(2,784	)
Exercise of options and RSUs			5,809			(3,126	)			—				—				—				2,683
Stock-based compensation			—			20,835				—				—				—				20,835
Distributions to limited liability company unit holders			—			—				—				—				(803	)			(803	)
Repurchase of Subordinate Voting Shares			—			(24,890	)			—				—				—				(24,890	)
Net income			—			—				—				33,051				851				33,902
Balance, September 30, 2023	$		1,702,344	$		16,052		$		12,973		$		(25,034	)	$		564		$		1,706,899

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

7

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Nine Months Ended September 30, 2023 and 2022

(Amounts Expressed in United States Dollars)

	Nine Months Ended September 30,
	2023			2022
	(in thousands)
CASH FLOW FROM OPERATING ACTIVITIES
Net income attributable to Green Thumb Industries Inc.	$	33,051		$	63,205
Net income attributable to non-controlling interest		851			1,360
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		73,363			71,706
Amortization of operating lease assets		35,996			31,906
Loss on disposal of property and equipment		2,815			1,514
Impairment of long-lived property and equipment		285			—
Loss on equity method investments		952			2,382
Loss (gain) from lease modification		87			(3,330	)
Stock-based compensation		20,835			19,362
Decrease in fair value of investments		153			2,770
Increase (decrease) in fair value of contingent consideration		3,370			(29,005	)
Decrease in fair value of warrants		(934	)		(19,876	)
Shares issued for settlement of business obligation		—			1,000
Gain on indemnification of deferred shares associated with post acquisition costs		(2,784	)		—
Amortization of debt discount		7,128			6,837
Changes in operating assets and liabilities:
Accounts receivable, net		(7,673	)		(8,691	)
Inventories, net		(2,870	)		(26,038	)
Prepaid expenses and other current assets		(1,129	)		(2,419	)
Deposits and other assets		536			(22	)
Accounts payable		4,084			(259	)
Accrued liabilities		4,052			(4,021	)
Operating lease liabilities		(32,114	)		(27,599	)
Income tax receivable and payable, net		13,818			7,438
NET CASH PROVIDED BY OPERATING ACTIVITIES		153,872			88,220
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment		(183,594	)		(119,870	)
Proceeds from disposal of property and equipment		319			112
Investments in securities and associates		(4,500	)		(5,804	)
Proceeds from equity investments and notes receivable		331			3,476
Settlement of acquisition consideration payable		—			(31,732	)
Purchase of businesses, net of cash acquired		—			(7,350	)
NET CASH USED IN INVESTING ACTIVITIES		(187,444	)		(161,168	)
CASH FLOW FROM FINANCING ACTIVITIES
Distributions to limited liability company unit holders		(803	)		(14,799	)
Contributions from unconsolidated subsidiaries		—			550
Repurchase of Subordinate Voting Shares		(24,890	)		—
Proceeds from exercise of options and RSUs		2,683			2,684
Proceeds from issuance of notes payable		16,654			2,102
Principal repayment of notes payable		(912	)		(751	)
NET CASH USED IN FINANCING ACTIVITIES		(7,268	)		(10,214	)
CASH AND CASH EQUIVALENTS:
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		(40,840	)		(83,162	)
CASH AND CASH EQUIVALENTS BEGINNING OF PERIOD		177,682			230,420
CASH AND CASH EQUIVALENTS END OF PERIOD	$	136,842		$	147,258

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

8

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Nine Months Ended September 30, 2023 and 2022

(Amounts Expressed in United States Dollars)

	Nine Months Ended September 30,
	2023			2022
	(in thousands)
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	$	15,564		$	13,699
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	$	(10,115	)	$	(10,217	)
Noncash increase in right of use asset	$	(5,599	)	$	(72,714	)
Noncash increase in lease liability	$	5,599		$	72,714
Mortgages associated with operating properties	$	—		$	7,350
Shares issued for purchase of noncontrolling interest	$	—		$	2,379
Issuance of shares associated with contingent consideration	$	12,524		$	13,111
Deferred share distributions	$	(20,454	)	$	—
Issuance of shares under business combinations	$	—		$	1,406
Acquisitions
Inventories	$	—		$	413
Accounts receivable		—			(153	)
Prepaid expenses		—			72
Property and equipment		—			738
Right of use assets		—			743
Identifiable Intangible assets		—			10,359
Goodwill		—			11,736
Deposits and other assets		—			12
Liabilities assumed		—			(712	)
Lease liabilities		—			(743	)
Noncontrolling interests		—			17,735
Contingent liabilities		—			(200	)
Equity interests issued		—			(3,785	)
Fair value of previously held equity interest		—			(14,500	)
Deferred income taxes		—			991
Settlement of noncontrolling interests		—			(15,356	)
	$	—		$	7,350
ADDITIONAL SUPPLEMENTAL INFORMATION
Decrease in fair value of investments	$	153		$	16,889
Increase in fair value of equity method investments		—			(14,119	)
TOTAL DECREASE IN FAIR VALUE OF INVESTMENTS	$	153		$	2,770

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

9

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation

(a) Description of Business

Green Thumb Industries Inc. (“Green Thumb,” the “Company,” “we” or “us”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail cannabis stores. The Company also owns and operates retail cannabis stores that include a rapidly growing national chain named RISE, which sell our products and third-party products. As of September 30, 2023, Green Thumb has revenue in fifteen markets (California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately 4,400 people and serves millions of patients and customers annually.

The Company’s registered office is located at 250 Howe Street, 20th Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters are at 325 W. Huron St., Suite 700, Chicago, IL 60654.

(b) Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, (the “2022 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.

(c) Significant Accounting Policies

There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2022 Form 10-K.

(d) Earnings per Share

Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of September 30, 2023, the Company had 10,229,895 options, 3,499,193 restricted stock units and 3,734,555 warrants outstanding. As of September 30, 2022, the Company had 9,725,907 options, 952,753 restricted stock units and 3,835,278 warrants outstanding.

10

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation (Continued)

(d) Earnings per Share (Continued)

In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended September 30, 2023, the computation of diluted earnings per share included 211,651 options and 618,525 restricted stock units. For the nine months ended September 30, 2023, the computation of diluted earnings per share included 153,215 options and 1,425,045 restricted stock units. There were no dilutive warrants during the three and nine months ended September 30, 2023 as the strike price was greater than the average stock price for the period. For the three months ended September 30, 2022, the computation of diluted earnings per share included 697,800 options, 57,128 restricted stock units and 46,998 warrants. For the nine months ended September 30, 2022, the computation of diluted earnings per share included 968,322 options, 226,564 restricted stock units and 131,631 warrants. For the three and nine months ended September 30, 2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,349,064 and 3,198,625, respectively. For the three and nine months ended September 30, 2022, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,052,822 and 2,192,896, respectively.

(e) Recently Issued Accounting Standards

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

11

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

2. INVENTORIES

The Company’s inventories include the following at September 30, 2023 and December 31, 2022:

		September 30, 2023		December 31, 2022
		(in thousands)
Raw Material	$	1,120	$	3,070
Packaging and Miscellaneous		10,756		9,847
Work in Process		45,072		57,287
Finished Goods		65,707		49,268
Reserve for Obsolete Inventory		(4,110)		(3,797)
Total Inventories, Net	$	118,545	$	115,675

3. PROPERTY AND EQUIPMENT

At September 30, 2023 and December 31, 2022, property and equipment consisted of the following:

		September 30, 2023		December 31, 2022
		(in thousands)
Buildings and Improvements	$	340,641	$	176,874
Equipment, Computers and Furniture		158,327		122,568
Leasehold Improvements		186,354		135,524
Land Improvements		995		847
Capitalized Interest		30,517		16,934
Total Property and Equipment		716,834		452,747
Less: Accumulated Depreciation		(113,507)		(80,702)
Property and Equipment, net		603,327		372,045
Land		33,725		29,106
Assets Under Construction		55,615		156,722
Property and Equipment, net	$	692,667	$	557,873

Assets under construction represent construction in progress related to both cultivation and retail store facilities not yet completed or otherwise not ready for use.

Depreciation expense for the three and nine months ended September 30, 2023 totaled $12,885 thousand and $35,266 thousand, respectively, of which $8,298 thousand and $23,348 thousand, respectively, is included in cost of goods sold. Depreciation expense for the three and nine months ended September 30, 2022 totaled $9,695 thousand and $26,844 thousand, respectively, of which $6,393 thousand and $17,357 thousand, respectively, is included in cost of goods sold.

12

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

4. INTANGIBLE ASSETS AND GOODWILL

(a) Intangible Assets

Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

At September 30, 2023 and December 31, 2022, intangible assets consisted of the following:

		September 30, 2023						December 31, 2022
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	146,739	$	513,977	$	660,716	$	113,800	$	546,916
Trademarks		41,511		12,655		28,856		41,511		10,486		31,025
Customer Relationships		24,438		16,054		8,384		24,438		13,435		11,003
Non-Competition Agreements		2,565		2,360		205		2,565		1,990		575
Total Intangible Assets	$	729,230	$	177,808	$	551,422	$	729,230	$	139,711	$	589,519

The Company recorded amortization expense for the three and nine months ended September 30, 2023 of $12,743 thousand and $38,097 thousand, respectively. The Company recorded amortization for the three and nine months ended September 30, 2022 of $14,823 thousand and $44,862 thousand, respectively.

The following table outlines the estimated annual amortization expense related to intangible assets as of September 30, 2023:

		Estimated Amortization
Year Ending December 31,		(in thousands)
Remainder of 2023	$	12,744
2024		50,392
2025		50,294
2026		47,332
2027		46,803
2028 and Thereafter		343,857
	$	551,422

As of September 30, 2023, the weighted average amortization period remaining for intangible assets was 11.60 years.

(b) Goodwill

At September 30, 2023 and December 31, 2022 the balances of goodwill, by segment, consisted of the following:

		Retail		Consumer Packaged Goods		Total
		(in thousands)
As of December 31, 2022	$	273,802	$	315,889	$	589,691
As of September 30, 2023	$	273,802	$	315,889	$	589,691

13

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

5. INVESTMENTS

As of September 30, 2023 and December 31, 2022, the Company held various equity interests in cannabis related companies as well as investments in note receivable instruments that had a combined fair value of $77,335 thousand and $74,169 thousand as of each period end, respectively. The Company measures its investments that do not have readily determinable fair value at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company performs an assessment on a quarterly basis to determine whether triggering events for impairment exist and to identify any observable price changes.

The following table summarizes the changes in the Company’s investments during the nine months ended September 30, 2023 and year ending December 31, 2022:

		September 30, 2023		December 31, 2022
	(in thousands)
Beginning	$	74,169	$	94,902
Additions		3,700		5,444
Disposals		(331)		(3,571)
Fair value adjustment		(153)		(22,606)
Transfers and other		(50)		—
Ending	$	77,335	$	74,169

During the three and nine months ended September 30, 2023, the Company recorded fair value gains (losses), net of interest income of $775 thousand and $(153) thousand, respectively. The fair value gains (losses) associated with the Company's equity investments in the amount of $724 thousand and $(410) thousand as of the three and nine months ended September 30, 2023, respectively, was recorded within other income (expense) on the Company's unaudited interim condensed consolidated statements of operations. The interest income portion associated with the Company's note receivable investments in the amount of $51 thousand and $257 thousand as of the three and nine months ended September 30, 2023, respectively was recorded within interest income on the unaudited interim condensed consolidated statements of operations.

(a) Equity Investments

As of September 30, 2023 and December 31, 2022, the Company held equity investments in publicly traded entities which have readily determinable fair values, which are classified as Level 1 investments, of $2,094 thousand and $2,535 thousand, respectively. During the three and nine months ended September 30, 2023, the Company recorded net gains (losses) on the change in fair value of such investments of $724 thousand and $(410) thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. During the three and nine months ended September 30, 2022, the Company recorded net gains (losses) on the change in fair value of such investments of $124 thousand and $(14,169) thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. During the nine months ended September 30, 2023 and 2022, the Company received proceeds from the sale of such investments of $31 thousand and $2,393 thousand, respectively. These investments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

As of September 30, 2023 and December 31, 2022, the Company held equity investments in privately held entities that did not have readily determinable fair values, which are classified as Level 3 investments, of $42,330 thousand and $40,330 thousand, respectively. For the three and nine months ended September 30, 2023, there were no gains or losses on the change in fair value of such investments. During the three and nine months ended September 30, 2022, the Company recorded net gains (losses) on the change in fair value of such investments of $(295) thousand and $182 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. There were no sales of these investments during these periods. These investments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

14

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

5. INVESTMENTS (Continued)

(a) Equity Investments (Continued)

Unrealized gains and (losses) recognized on equity investments held during the three and nine months ended September 30, 2023 were $660 thousand and $(350) thousand, respectively. Unrealized losses recognized on equity investments held during the three and nine months ended September 30, 2022 were $137 thousand and $(13,825) thousand, respectively.

(b) Note Receivable Instruments

The Company has made multiple investments in various note receivable instruments, including note receivable instruments with conversion features.

The Company held note receivable instruments, which were classified as a Level 1 investment as they represent public debt of a publicly traded entity, and had a fair value of $22,214 thousand as of September 30, 2023 and December 31, 2022. During the three and nine months ended September 30, 2023, there were no gains or (losses) on the change in fair value of such investments. For the three and nine months ended September 30, 2022, the Company recorded net gains (losses) on the change in fair value of such investments of $418 thousand and $(236) thousand, respectively within other income (expense) on the unaudited interim condensed consolidated statements of operations. The note receivable instruments have a stated interest rate of 13% and a maturity date of April 30, 2025. These note receivable instruments did not contain conversion features and are currently classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

As of September 30, 2023 and December 31, 2022, the Company held note receivable instruments which were classified as Level 3 investments as they represent loans provided to privately held entities that do not have readily determinable fair values. The note receivable instruments had a combined fair value of $10,697 thousand and $9,090 thousand, respectively, with stated interest ranging between 0.91% and 10% and terms between 9 months to five years. During the three and nine months ended September 30, 2023, there were no gains or (losses) recorded on the change in fair value of such investments, however, the company recorded accrued interest of $51 thousand and $257 thousand, respectively, within interest income on the unaudited interim condensed consolidated statements of operations. During the three and nine months ended September 30, 2022, the Company recorded net losses on the change in fair value of such investments of $0 thousand and $3,145 thousand, respectively, within other income (expense) and accrued interest of $185 thousand and $479 thousand, respectively, within interest income on the unaudited interim condensed consolidated statements of operations. These note receivable instruments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

15

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

6. LEASES

(a) Operating Leases

The Company has operating leases for its retail stores and processing and cultivation facilities located throughout the U.S., as well as corporate office space located in Illinois. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date.

All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for fixed and variable non-lease components, such as taxes, insurance and maintenance. The Company accounts for each real estate lease and the related non-lease components together as a single component.

The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. For the three and nine months ended September 30, 2023, the Company recorded operating lease expense of $11,628 thousand and $35,996 thousand, respectively compared to operating lease expense of $11,884 thousand and $31,906 thousand for the three and nine months ended September 30, 2022, respectively.

Other information related to operating leases as of September 30, 2023 and December 31, 2022 were as follows:

	September 30, 2023	December 31, 2022
Weighted average remaining lease term (years)	11.98	11.64
Weighted average discount rate	12.41%	12.42%

Maturities of lease liabilities for operating leases as of September 30, 2023 were as follows:

		Maturities of Lease Liability
Year Ending December 31,		Third Party		Related Party		Total
		(in thousands)
Remainder of 2023	$	10,669	$	143	$	10,812
2024		43,250		437		43,687
2025		41,114		343		41,457
2026		40,409		350		40,759
2027		40,793		357		41,150
2028 and Thereafter		358,013		1,728		359,741
Total Lease Payments		534,248		3,358		537,606
Less: Interest		(274,503)		(1,268)		(275,771)
Present Value of Lease Liability	$	259,745	$	2,090	$	261,835

(b) Related Party Operating Leases

The Company has leasing arrangements that are related party transactions, including for certain facilities in Maryland, Massachusetts and Nevada. Wendy Berger, a director of the Company, is a principal of WBS Equities, LLC, which is the Manager of Mosaic Real Estate, LLC, and owns the facilities leased by the Company. Additionally, Mosaic Real Estate, LLC is indirectly owned in part by Ms. Berger (through the Wendy Berger 1998 Revocable Trust), Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (through KP Capital, LLC), and Anthony Georgiadis, the President and a director of the Company (through Three One Four Holdings, LLC). The terms of these leases range from 7 years to 15 years. For the three and nine months ended September 30, 2023, the Company recorded lease expense of $139 thousand and $415 thousand, respectively, compared to lease expense of $296 thousand and $886 thousand for the three and nine months ended September 30, 2022, respectively.

16

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

7. NOTES PAYABLE

At September 30, 2023 and December 31, 2022, notes payable consisted of the following:

		September 30, 2023		December 31, 2022
		(in thousands)
Charitable Contributions1	$	400	$	764
Private placement debt dated April 30, 20212		244,623		237,795
Mortgage notes3		53,518		37,109
Total notes payable		298,541		275,668
Less: current portion of notes payable		(1,466)		(1,037)
Notes payable, net of current portion	$	297,075	$	274,631

1 In connection with acquisitions completed in 2017 and 2019, the Company is required to make quarterly charitable contributions of $50 thousand through October 2024 and annual charitable contributions of $250 thousand through May 2024, respectively. The net present value of these required payments has been recorded as a liability with interest rates ranging between 2.17% - 7.00%.

2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in a total amount of $249,934 thousand with an interest rate of 7.00%, maturing on April 30, 2025. The April 30, 2021 Notes were issued at a discount, the carrying value of which was $5,311 thousand and $12,139 thousand as of September 30, 2023 and December 31, 2022, respectively.

3 Mortgage notes with an initial value of $55,017 thousand and $38,292 thousand, respectively, were issued by the Company in connection with various operating properties, and were recorded at such gross value as of September 30, 2023 and December 31, 2022. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00% and 9.50%. The mortgage notes were issued at a discount, the carrying value of which was $237 thousand and $437 thousand, respectively, and are presented net of principal payments of $1,262 thousand and $746 thousand as of September 30, 2023 and December 31, 2022, respectively.

(b) Related Parties

A portion of the April 30, 2021 Notes are held by related parties as well as unrelated third-party lenders at a percentage of approximately 1% and 99%, respectively. The related parties consist of Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (held through KP Capital, LLC and Outsiders Capital, LLC); Andrew Grossman, the Executive Vice President of Capital Markets of the Company (held through AG Funding Group, LLC); Anthony Georgiadis, the President and a director of the Company (held through Three One Four Holdings, LLC and ABG, LLC).

17

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

8. WARRANTS

As part of the terms of the Company's issuance of the April 30, 2021 Notes, as well as other financing arrangements, the Company issued warrants to related parties, as well as unrelated third parties, which allow the holders to purchase Subordinate Voting Shares at an exercise price determined at the time of issuance.

The following table summarizes the number of warrants outstanding as of September 30, 2023 and December 31, 2022:

	Liability Classified							Equity Classified
	Number of Shares			Weighted Average Exercise Price (C$)		Weighted Average Remaining Contractual Life		Number of Shares			Weighted Average Exercise Price (USD)		Weighted Average Remaining Contractual Life
Balance as of December 31, 2022		1,997,208	C$		18.03		1.50		1,737,347	$		31.83		3.38
Balance as of September 30, 2023		1,997,208	C$		18.03		0.75		1,737,347	$		31.83		2.63

(a) Liability Classified Warrants Outstanding

The following table summarizes the fair value of the liability classified warrants at September 30, 2023 and December 31, 2022:

				Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		September 30, 2023		December 31, 2022		Change
				(in thousands)
Private Placement Financing Warrants Issued May 2019	C$19.39		1,606,533	$	1,820	$	3,125	$	(1,305	)
Modification Warrants Issued November 2019	C$12.04		316,947		1,434		1,139		295
Additional Modification Warrants Issued May 2020	C$14.03		73,728		332		256		76
Totals			1,997,208	$	3,586	$	4,520	$	(934	)

During the three and nine months ended September 30, 2023 and 2022, the Company recorded a loss of $1,329 thousand, a gain of $934 thousand, a loss of $1,896 thousand and a gain of $19,876 thousand, respectively, on the change in the fair value of the warrant liability within other income (expense) on the unaudited interim condensed consolidated statements of operations. As of September 30, 2023, the warrant liability was classified as a current liability, and recorded within accrued liabilities on the unaudited interim condensed consolidated balance sheets.

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 13 - Fair Value Measurements for additional details):

	September 30,	December 31,
Significant Assumptions	2023	2022
Volatility	59.08% - 76.33%	70.44% - 78.21%
Remaining Term	0.64-1.64 years	1.39 - 2.39 years
Risk Free Rate	4.83%	3.82% - 4.07%

18

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

8. WARRANTS (Continued)

(b) Equity Classified Warrants Outstanding

The Company's equity classified warrants were recorded at fair value at each respective date of issuance. Equity classified warrants are not remeasured at fair value on a recurring basis and are carried at their issuance date fair value. The following table summarizes the carrying amounts of the Company's equity classified warrants at September 30, 2023 and December 31, 2022:

					Issuance Date Fair Value
			Warrants		September 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price		Outstanding		2023		2022
					(in thousands)
Mortgage Warrants Issued June 2020	$	9.10		35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$	32.68		1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$	30.02		243,303		2,616		2,616
Totals				1,737,347	$	25,056	$	25,056

The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date:

Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%

19

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL

Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares, are classified as equity. Incremental costs directly attributable to the issuance of common shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the applicable vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes.

(a) Authorized

The Company has the following classes of share capital, with each class having no par value:

(i) Subordinate Voting Shares

The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares. During the three months ended September 30, 2023, shareholders of the Company converted 25,000 Multiple Voting Shares into 2,500,000 Subordinate Voting Shares.

(ii) Multiple Voting Shares

Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. At September 30, 2023, the Company had 38,531 issued and outstanding Multiple Voting Shares, which convert into 3,853,100 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple Voting Shares. During the three months ended September 30, 2023, shareholders of the Company converted 25,000 Super Voting Shares into 25,000 Multiple Voting Shares and 25,000 Multiple Voting Shares into 2,500,000 Subordinate Voting Shares.

(iii) Super Voting Shares

Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for one Multiple Voting Share. At September 30, 2023, the Company had 226,690 issued and outstanding Super Voting Shares which ultimately convert into 22,669,000 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Super Voting Shares. During the three months ended September 30, 2023, shareholders of the Company converted 25,000 Super Voting Shares into 25,000 Multiple Voting Shares.

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2023	206,991,275	38,531	251,690
Distribution of contingent consideration	1,614,871	—	—
Distribution of deferred shares	680,089	—	—
Issuance of shares upon exercise of options	365,521	—	—
Issuances of shares upon vesting of RSUs	390,676	—	—
Repurchase of Subordinate Voting Shares	(2,500,001)	—	—
Exchange of shares	2,500,000	—	(25,000)
As at September 30, 2023	210,042,431	38,531	226,690

20

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL (Continued)

(b) Issued and Outstanding (Continued)

(i) Distribution of Deferred Shares

As part of the consideration exchanged for certain acquisitions completed throughout 2021, the Company deferred the distribution of Subordinate Voting Shares to secure the Company's indemnification rights associated with post-acquisition costs. The following table summarizes the activity during the nine months ended September 30, 2023:

Related Acquisition	As at December 31, 2022	Distributed Shares	Cancelled Shares	As at September 30, 2023
Liberty Compassion, Inc.	214,768	(214,768)	—	—
Dharma Pharmaceuticals, LLC	229,878	(229,878)	—	—
Mobley Pain Management and Wellness Center, LLC and Canwell Processing, LLC	264,760	(12,305)	(84,122)	168,333
GreenStar Herbals, Inc.	161,306	(161,306)	—	—
Maryland Health and Wellness Center, Inc.	61,832	(61,832)	—	—
LeafLine Industries, LLC	386,002	—	—	386,002
Total	1,318,546	(680,089)	(84,122)	554,335

As of September 30, 2023 and December 31, 2022, the Company held deferred shares in the amount of $12,973 thousand and $36,211 thousand, respectively. In accordance with the relevant acquisition agreement, a portion of the outstanding deferred shares were cancelled in order to indemnify the Company for post-acquisition costs. As the cancellation of the deferred shares occurred outside of the purchase price allocation measurement period (generally one year from the acquisition date), the Company recorded a gain of $2,784 thousand within selling general and administrative expenses on the Company's unaudited interim condensed consolidated statements of operations during the nine months ended September 30, 2023.

(ii) Distribution of Contingent Consideration

Dharma Pharmaceuticals, LLC

In connection with the Company's 2021 acquisition of Dharma Pharmaceuticals, LLC (“Dharma”), the purchase agreement included contingent consideration of up to $65,000 thousand in Subordinate Voting Shares of Green Thumb, dependent upon the successful opening of up to five retail stores in the Virginia area within the first three years following the signing of the agreement and the legal sale of adult-use cannabis in a retail store by January 1, 2025. On June 1, 2023 and July 10, 2023, the Company issued 822,447 and 792,424 Subordinate Voting Shares, respectively, to the former owners of Dharma in connection with the successful opening of the fourth and fifth retail stores in Virginia. The shares had a combined fair value of $12,524 thousand at the date of issuance.

As of September 30, 2023 and December 31, 2022, the total estimated fair value of the contingent consideration associated with the acquisition of Dharma, which was valued based on the probability weighting of potential payouts, was $32,789 thousand, and $41,943 thousand, respectively. As of December 31, 2022, $11,400 thousand of the total value of the contingent consideration was included within current liabilities on the Company's unaudited interim condensed consolidated balance sheets. As of September 30, 2023, no portion of the contingent consideration was included within current liabilities on the Company's unaudited interim condensed consolidated balance sheets.

(iii) Repurchase of Subordinate Voting Shares

On September 5, 2023, the Company announced that its Board of Directors authorized the Company to repurchase up to 5%, or 10,486,951 of its Subordinate Voting Shares over a 12-month period at an aggregate cost of up to $50,000 thousand. During the month of September 2023, the Company repurchased 2,500,000 Subordinate Voting Shares at an average price of $9.96 per share.

21

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL (Continued)

(c) Stock-Based Compensation

The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity.

In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1 and Amendment No. 2 thereto (as amended, the “Plan”). The maximum number of Restricted Stock Units (“RSUs”) and options outstanding under the Plan at any time shall not exceed 10% of the then issued and outstanding shares on an as-converted basis.

The Company recognizes compensation expense for RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized.

Option and RSU awards generally vest over three years, and options typically have a life of five to ten years. Option grants under the Plan are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant.

Stock option activity is summarized as follows:

	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life
Balance as of December 31, 2022	9,577,947	$12.71	4.80
Granted	2,321,729	7.72	6.50
Exercised	(365,521)	7.34
Forfeited	(1,304,260)	12.25
Balance as of September 30, 2023	10,229,895	$11.82	4.60
Vested	5,341,985	$17.24
Exercisable as of September 30, 2023	3,566,406	$7.99	2.84

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2023 and the year ended December 31, 2022, using the following ranges of assumptions:

	September 30,	December 31,
	2023	2022
Risk-free interest rate	3.06% - 4%	1.18% - 3.54%
Expected dividend yield	0%	0%
Expected volatility	64%	60% - 64%
Expected option life	3.5 – 4.5 years	3 – 4.5 years

As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.

22

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

9. SHARE CAPITAL (Continued)

(c) Stock-Based Compensation (Continued)

The following table summarizes the number of unvested RSU awards as of September 30, 2023 and December 31, 2022 and the changes during the nine months ended September 30, 2023:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2022	947,502	$	17.91
Granted	3,307,909		7.67
Forfeited	(365,542)		10.83
Vested	(390,676)		15.50
Unvested Shares at September 30, 2023	3,499,193	$	9.24

The stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Stock options expense	$	4,009	$	6,003	$	12,795	$	12,985
Restricted Stock Units		3,206		1,875		8,040		6,377
Total Stock Based Compensation Expense	$	7,215	$	7,878	$	20,835	$	19,362

As of September 30, 2023, $45,048 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.05 years.

23

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

10. INCOME TAX EXPENSE

The following table summarizes the Company’s income tax expense and effective tax rates for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
Income before Income Taxes	$	45,333	$	43,117	$	127,829	$	167,005
Income Tax Expense		34,526		32,969		93,927		102,440
Effective Tax Rate		76.2%		76.5%		73.5%		61.3%

The effective tax rates for the three and nine months ended September 30, 2023 and 2022 were based on the Company’s forecasted annualized effective tax rates and were adjusted for discrete items that occurred within the periods presented.

Due to its cannabis operations, the Company is subject to the limitations of the U.S. Internal Revenue Code of 1986, as amended (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income and provides for effective tax rates that are well in excess of statutory tax rates.

Taxes paid during the nine months ended September 30, 2023 and 2022 were $80,398 thousand and $95,307 thousand, respectively.

24

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

11. OTHER INCOME (EXPENSE)

For the three and nine months ended September 30, 2023 and 2022 other income (expense) was comprised of the following:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	724	$	247	$	(410)	$	(17,368)
Fair value adjustments on equity method investments		—		—		—		14,119
Fair value adjustments on warrants issued		(1,329)		(1,896)		934		19,876
Earnings (loss) from equity method investments		(202)		(441)		(952)		(2,382)
Other		176		5		451		688
Total Other Income (Expense)	$	(631)	$	(2,085)	$	23	$	14,933

12. COMMITMENTS AND CONTINGENCIES

The Company is subject to lawsuits, investigations and other claims related to employment, commercial and other matters that arise out of operations in the normal course of business. Periodically, the Company reviews the status of each significant matter and assesses the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably estimated, such amount is recognized in other liabilities.

Contingent liabilities are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period and are discounted to present value where the effect is material. The Company performs evaluations to identify contingent liabilities for contracts. Contingent consideration is measured upon acquisition and is estimated using probability weighting of potential payouts. Subsequent changes in the estimated contingent consideration from the final purchase price allocation are recognized in the Company’s unaudited interim condensed consolidated statements of operations.

(a) Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, sanctions, restrictions on its operations, or losses of permits that could result in the Company ceasing operations in that specific state or local jurisdiction. The Company may be subject to regulatory fines, penalties, or restrictions in the future as cannabis and other regulations continue to evolve and are subject to differing interpretations.

(b) Claims and Litigation

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. The following is an update to the status of previously disclosed matters as of September 30, 2023:

Cresco Labs New York, LLC and Cresco Labs LLC (“Plaintiffs”) filed an amended complaint against one of the Company’s subsidiaries, Fiorello Pharmaceuticals, Inc. (“Defendant”) on November 20, 2018, in the Supreme Court of the State of New York, alleging Defendant breached the parties’ Equity Purchase Agreement Letter of Intent (“LOI”) relating to the acquisition of Defendant by Plaintiffs. As of September 30, 2023, the Company believed the potential exposure associated with the complaint was de minimis and reduced the estimated liability accordingly. Subsequently, on October 18, 2023, all pending motions were withdrawn and Plaintiffs' claims were dismissed with prejudice.

At September 30, 2023, there were no other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s consolidated operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest.

(c) Construction Commitments

As of September 30, 2023, the Company held approximately $7,100 thousand of open construction commitments to contractors on work being performed.

25

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

13. FAIR VALUE MEASUREMENTS

The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3 – Inputs for the asset or liability that are not based on observable market data.

(a) Financial Instruments

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, investments, accounts payable and accrued liabilities, notes payable, warrant liability, and contingent consideration payable.

It was not practicable to estimate the fair value of the Company's long-term notes payable, which consist of charitable contributions, private placement debt and mortgage notes, since there were no quoted prices or active trading markets. The carrying amount of notes payable at September 30, 2023 and December 31, 2022 was $298,541 thousand and $275,668 thousand, which includes $1,466 thousand and $1,037 thousand, respectively, of short-term debt due within one year.

Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements. The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:

		As of September 30, 2023
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	136,842	$	—	$	—	$	136,842
Investments		24,308		—		53,027		77,335
Contingent Consideration Payable		—		—		(32,789)		(32,789)
Warrant Liability		—		—		(3,586)		(3,586)
	$	161,150	$	—	$	16,652	$	177,802

		As of December 31, 2022
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	177,682	$	—	$	—	$	177,682
Investments		24,749		—		49,420		74,169
Contingent Consideration Payable		—		—		(41,943)		(41,943)
Warrant Liability		—		—		(4,520)		(4,520)
	$	202,431	$	—	$	2,957	$	205,388

26

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

14. SEGMENT REPORTING

The Company operates in two segments: the cultivation, production and sale of cannabis products to retail stores (“Consumer Packaged Goods”) and retailing of cannabis to patients and consumers (“Retail”). The Company does not allocate operating expenses to these business units, nor does it allocate specific assets. Additionally, the Chief Operating Decision Maker does not review total assets or net income (loss) by segments; therefore, such information is not presented below.

The below table presents revenues by type for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	205,441	$	199,632	$	582,363	$	564,951
Consumer Packaged Goods		150,425		127,676		412,096		368,692
Intersegment Eliminations		(80,468)		(66,114)		(218,137)		(175,538)
Total Revenues, Net of Discounts	$	275,398	$	261,194	$	776,322	$	758,105
Depreciation and Amortization
Retail	$	9,598	$	9,921	$	27,539	$	29,881
Consumer Packaged Goods		16,030		14,597		45,824		41,825
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	25,628	$	24,518	$	73,363	$	71,706
Income Taxes
Retail	$	18,551	$	18,589	$	50,890	$	58,460
Consumer Packaged Goods		15,975		14,380		43,037		43,980
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	34,526	$	32,969	$	93,927	$	102,440

Goodwill assigned to the Consumer Packaged Goods segment as of September 30, 2023 and December 31, 2022 was $315,889 thousand and $315,889 thousand, respectively. Intangible assets, net assigned to the Consumer Packaged Goods segment as of September 30, 2023 and December 31, 2022 was $266,884 thousand and $286,922 thousand, respectively.

Goodwill assigned to the Retail segment as of September 30, 2023 and December 31, 2022 was $273,802 thousand and $273,802 thousand, respectively. Intangible assets, net assigned to the Retail segment as of September 30, 2023 and December 31, 2022 was $284,538 thousand and $302,597 thousand, respectively.

The Company’s assets are aggregated into two reportable segments (Retail and Consumer Packaged Goods). For the purposes of testing goodwill, Green Thumb has identified two reporting units which align with our reportable segments (Retail and Consumer Packaged Goods). All revenues are derived from customers domiciled in the United States and all assets are located in the United States.

27

ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Green Thumb Industries Inc. (the “Company” or “Green Thumb”) is for the three and nine months ended September 30, 2023 and 2022. It is supplemental to, and should be read in conjunction with, the Company’s unaudited interim condensed consolidated financial statements as of September 30, 2023 and the consolidated financial statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission on March 1, 2023 (the “2022 Form 10-K”) and the accompanying notes for each respective period. The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Financial information presented in this MD&A is presented in United States dollars (“$” or “US$”), unless otherwise indicated.

This MD&A contains certain “forward-looking statements” and certain “forward-looking information” as defined under applicable United States securities laws. Please refer to the discussion of forward-looking statements and information set out under the heading “Disclosure Regarding Forward-Looking Statements,” identified in the ‘‘Risks and Uncertainties’’ section of this MD&A and in Part II, Item 1A, “Risk Factors of the 2022 Form 10-K.” As a result of many factors, the Company’s actual results may differ materially from those anticipated in these forward-looking statements and information.

OVERVIEW OF THE COMPANY

Established in 2014 and headquartered in Chicago, Illinois, Green Thumb promotes well-being through the power of cannabis through branded consumer packaged goods and people-first retail experiences, while giving back to the communities in which it serves. As of September 30, 2023, Green Thumb has operations in fifteen U.S. markets, employs approximately 4,400 people and serves millions of patients and customers annually.

Green Thumb’s core business is manufacturing, distributing and marketing a portfolio of owned cannabis consumer packaged goods brands (which we refer to as our Consumer Packaged Goods business), including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RYTHM. The Company distributes and markets these products primarily to third-party licensed retail cannabis stores across the United States as well as to Green Thumb-owned retail stores (which we refer to as our Retail business).

The Company’s Consumer Packaged Goods portfolio is primarily generated from plant material that Green Thumb grows and processes itself, which we use to produce our consumer packaged goods in eighteen manufacturing facilities. This portfolio consists of stock keeping units across a range of cannabis product categories, including flower, pre-rolls, concentrates, vape, capsules, tinctures, edibles, topicals and other cannabis-related products (none of which are individually material to the Company). These Consumer Packaged Goods products are sold in retail stores throughout the U.S. including at Green Thumb’s own RISE and other retail stores.

Green Thumb owns and operates a national cannabis retail chain called RISE that provides relationship-centric retail experiences aimed to deliver a superior level of customer service through high-engagement consumer interaction, a consultative, transparent and education-forward selling approach and a consistently available assortment of cannabis products. In addition, Green Thumb owns retail stores under other names, primarily where naming is subject to licensing or similar restrictions or in certain instances where we co-own the store. The income from Green Thumb’s retail stores is primarily derived from the sale of cannabis-related products, which includes the sale of Green Thumb produced products as well as those produced by third parties, with an immaterial (under 10%) portion of this income resulting from the sale of other merchandise (such as t-shirts and accessories for cannabis use). The RISE stores currently are located in fourteen of the states in which we operate. As of September 30, 2023, the Company had 85 open and operating retail stores. The Company’s new store opening plans is fluid, depending on market conditions, obtaining local licensing, construction and other permissions and subject to the Company’s capital allocation plans.

28

Results of Operations – Consolidated

The following table sets forth the Company’s selected consolidated financial results for the periods, and as of the dates, indicated. The (i) unaudited interim condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 and (ii) unaudited interim condensed consolidated balance sheet as of September 30, 2023 and December 31, 2022 have been derived from, and should be read in conjunction with, the unaudited interim condensed consolidated financial statements and accompanying notes presented in Item 1 of this quarterly report on Form 10-Q.

The Company’s unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on a going-concern basis that contemplates continuity of operations and realization of assets and liquidation of liabilities in the ordinary course of business.

		Three Months Ended September 30,				Nine Months Ended September 30,				QTD Change			YTD Change
		2023		2022		2023		2022		$	%		$	%
		(in thousands, except share and per share amounts)								Increase (Decrease)
Revenues, Net of Discounts	$	275,398	$	261,194	$	776,322	$	758,105	$	14,204	5%	$	18,217	2%
Cost of Goods Sold, Net		(141,592)		(129,954)		(392,515)		(378,127)		11,638	9%		14,388	4%
Gross Profit		133,806		131,240		383,807		379,978		2,566	2%		3,829	1%
Expenses:
Selling, General, and Administrative		84,779		82,479		249,515		214,402		2,300	3%		35,113	16%
Total Expenses		84,779		82,479		249,515		214,402		2,300	3%		35,113	16%
Income From Operations		49,027		48,761		134,292		165,576		266	1%		(31,284)	(19)%
Total Other Income (Expense)		(3,694)		(5,644)		(6,463)		1,429		1,950	35%		(7,892)	(552)%
Income Before Provision for Income Taxes And Non-Controlling Interest		45,333		43,117		127,829		167,005		2,216	5%		(39,176)	(23)%
Provision for Income Taxes		34,526		32,969		93,927		102,440		1,557	5%		(8,513)	(8)%
Net Income Before Non-Controlling Interest		10,807		10,148		33,902		64,565		659	6%		(30,663)	(47)%
Net Income Attributable to Non-Controlling Interest		295		319		851		1,360		(24)	(8)%		(509)	(37)%
Net Income Attributable To Green Thumb Industries Inc.	$	10,512	$	9,829	$	33,051	$	63,205	$	683	7%	$	(30,154)	(48)%
Net Income Per Share - Basic	$	0.05	$	0.04	$	0.14	$	0.27	$	0.01	25%	$	(0.13)	(48)%
Net Income Per Share - Diluted	$	0.05	$	0.04	$	0.14	$	0.26	$	0.01	25%	$	(0.12)	(46)%
Weighted Average Number of Shares Outstanding – Basic		239,459,783		237,002,873		238,248,852		236,546,078
Weighted Average Number of Shares Outstanding – Diluted		240,289,959		237,804,799		239,827,112		237,872,595

		September 30, 2023		December 31, 2022
		(in thousands)
Total Assets	$	2,499,212	$	2,433,528
Long-Term Liabilities	$	642,431	$	621,525

Three Months Ended September 30, 2023 Compared to the Three Months Ended September 30, 2022

Revenues, net of Discounts

Revenue for the three months ended September 30, 2023 was $275,398 thousand, an increase of 5% from $261,194 thousand for the three months ended September 30, 2022. The increase in revenue was largely due to legalization of adult-use sales in Maryland, which began on July 1, 2023.

The Company generated revenue from 85 retail stores during the quarter, compared to 77 in the same quarter of the prior year. During the three months ended September 30, 2023, the Company opened one retail store in Nevada, and one retail store in Florida.

Cost of Goods Sold, net

Cost of goods sold are derived from retail purchases made by the Company from its third-party licensed producers operating within our state markets and costs related to the internal cultivation and production of cannabis. Cost of goods sold for the three months ended September 30, 2023 was $141,592 thousand, an increase of 9% from $129,954 thousand for the three months ended September 30, 2022, driven by increased volume from the launch of adult-use sales in Maryland as described above, and new retail store openings in Nevada and Florida.

29

Gross Profit

Gross profit for the three months ended September 30, 2023 was $133,806 thousand, representing a gross margin on the sale of branded cannabis flower and processed and packaged products including concentrates, edibles, topicals and other cannabis products, of 49%. This is compared to gross profit for the three months ended September 30, 2022 of $131,240 thousand, or a 50% gross margin. The decrease in gross margin (percent) was primarily driven by price compression. The increase in gross profit (dollars) was directly attributable to the revenue increase as described above.

Total Expenses

Total expenses for the three months ended September 30, 2023 were $84,779 thousand, or 31% of revenues, net of discounts, resulting in an increase of $2,300 thousand over the same period in the prior year. Total expenses for the three months ended September 30, 2022 were $82,479 thousand or 32% of revenues, net of discounts. The increase in total expense for the three months ended September 30, 2023 was attributable to an increase in retail salaries and benefits and other operational and facility expenses, mainly as a result of the legalization of adult-use sales in Maryland, which began on July 1, 2023, as well as new locations opened since September 30, 2022.

Total Other Income (Expense)

Total other income (expense) for three months ended September 30, 2023 was $(3,694) thousand, an increase of $1,950 thousand, primarily due to favorable fair value adjustments to the Company's equity investments, as well as a reduction in unfavorable fair value adjustments to the Company's warrant liability recorded during the three months ended September 30, 2023.

Income (Loss) Before Provision for Income Taxes and Non-Controlling Interest

Income before provision for income taxes and non-controlling interest for the three months ended September 30, 2023 was $45,333 thousand, an increase of $2,216 thousand compared to the three months ended September 30, 2022.

As presented under the heading “Non-GAAP Measures” below, after adjusting for non-cash equity incentive compensation of $7,215 thousand and $7,878 thousand in the three months ended September 30, 2023 and 2022, respectively, and other nonoperating (income) expenses, of $1,119 thousand and $3,306 thousand in the three months ended September 30, 2023 and 2022, respectively, adjusted earnings before interest, depreciation, and amortization (“EBITDA”) was $82,989 thousand and $84,463 thousand, respectively.

Provision for Income Taxes

Income tax expense is recognized based on the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end. For the three months ended September 30, 2023, federal and state income tax expense totaled $34,526 thousand compared to expense of $32,969 thousand for the three months ended September 30, 2022.

30

Nine Months Ended September 30, 2023 Compared to the Nine Months Ended September 30, 2022

Revenues, net of Discounts

Revenue for the nine months ended September 30, 2023 was $776,322 thousand, an increase of 2% from $758,105 for the nine months ended September 30, 2022. The increase in revenue was largely due to legalization of adult-use sales in New Jersey, which began on April 21, 2022, legalization of adult-use sales in Maryland, which began on July 1, 2023, legalization of adult-use sales in Connecticut, which began on January 10, 2023, continued growth in existing markets, as well as revenue generated from new retail stores opened in the current period, partially offset by price compression.

The Company generated revenue from 85 retail stores during the period compared to 77 in the same period of the prior year. During the nine months ended September 30, 2023, the Company opened two retail stores in Pennsylvania, two retail stores in Virginia, one retail store in Minnesota, two retail stores in Nevada, and one retail store in Florida.

Cost of Goods Sold, net

Cost of goods sold are derived from retail purchases made by the Company from its third-party licensed producers operating within our state markets and costs related to the internal cultivation and production of cannabis. Cost of goods sold for the nine months ended September 30, 2023 was $392,515 thousand, an increase of 4% from $378,127 thousand for the nine months ended September 30, 2022, driven by increased volume from the launch of adult-use sales in New Jersey and Maryland as described above, and new retail store openings in Pennsylvania, Virginia, Minnesota, Nevada and Florida.

Gross Profit

Gross profit for the nine months ended September 30, 2023 was $383,807 thousand, representing a gross margin on the sale of branded cannabis flower and processed and packaged products including concentrates, edibles, topicals and other cannabis products, of 49%. This is compared to gross profit for the nine months ended September 30, 2022 of $379,978 thousand or a 50% gross margin. The decrease in gross margin (percent) was primarily driven by price compression. The increase in gross profit (dollars) was directly attributable to the revenue increase as described above.

Total Expenses

Total expenses for the nine months ended September 30, 2023 were $249,515 thousand or 32% of revenues, net of discounts, resulting in an increase of $35,113 thousand over the same period in the prior year. Total expenses for the nine months ended September 30, 2022 were $214,402 thousand or 28% of revenues, net of discounts. Total expenses were lower in the first nine months of 2022 primarily due to favorable fair value adjustments associated with the remeasurement of the Company's contingent consideration arrangements recorded during the nine months ended September 30, 2022.

Total Other Income (Expense)

Total other income (expense) for the nine months ended September 30, 2023 was $(6,463) thousand, a decrease of $7,892 thousand over the same period in the prior year, primarily due to a one-time favorable fair value adjustment associated with the Company's acquisition of ILDISP, LLC recorded during nine months ended September 30, 2022, partially offset by an increase in capitalized interest during the nine months ended September 30, 2023.

Income (Loss) Before Provision for Income Taxes and Non-Controlling Interest

Net operating income before provision for income taxes and non-controlling interest for the nine months ended September 30, 2023 was $127,829 thousand, a decrease of $39,176 thousand compared to the nine months ended September 30, 2022.

As presented under the heading “Non-GAAP Measures” below, after adjusting for non-cash equity incentive compensation of $20,835 thousand and $19,362 thousand, and other nonoperating (income) expenses, of $6,549 thousand and $(26,405) thousand in the nine months ended September 30, 2023 and 2022, respectively, Adjusted EBITDA was $235,039 thousand and $230,239 thousand, respectively.

31

Provision for Income Taxes

Income tax expense is recognized based on the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end. For the nine months ended September 30, 2023, federal and state income tax expense totaled $93,927 thousand compared to expense of $102,440 thousand for the nine months ended September 30, 2022.

Results of Operations by Segment

The following table summarizes revenues net of sales discounts by segment for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				2023 vs. 2022
		2023		2022		$ Change	% Change
		(in thousands)				Increase (Decrease)
Retail	$	205,441	$	199,632	$	5,809	3%
Consumer Packaged Goods		150,425		127,676		22,749	18%
Intersegment Eliminations		(80,468)		(66,114)		14,354	22%
Total Revenues, Net of Discounts	$	275,398	$	261,194	$	14,204	5%

		Nine Months Ended September 30,				2023 vs. 2022
		2023		2022		$ Change	% Change
		(in thousands)				Increase (Decrease)
Retail	$	582,363	$	564,951	$	17,412	3%
Consumer Packaged Goods		412,096		368,692		43,404	12%
Intersegment Eliminations		(218,137)		(175,538)		42,599	24%
Total Revenues, Net of Discounts	$	776,322	$	758,105	$	18,217	2%

Three Months Ended September 30, 2023 Compared with the Three Months Ended September 30, 2022

Revenues, net of discounts, for the Retail segment were $205,441 thousand, an increase of $5,809 thousand or 3%, compared to the three months ended September 30, 2022. The increase in revenue was primarily due to the legalization of adult-use sales in Maryland, which began on July 1, 2023, partially offset by price compression.

Revenues, net of discounts, for the Consumer Packaged Goods Segment were $150,425 thousand, an increase of $22,749 thousand or 18%, compared to the three months ended September 30, 2022. The increase in Consumer Packaged Goods revenues was primarily due to the legalization of adult-use sales in Maryland, which began on July 1, 2023, as well as the legalization of adult-use sales in Connecticut, which began on January 10, 2023.

Intersegment eliminations associated with the Consumer Packaged Goods Segment were $80,468 thousand, an increase of $14,354 thousand or 22% compared to the three months ended September 30, 2022. The increase in intersegment eliminations was driven by increased intercompany sales to Company-owned retail stores primarily in Pennsylvania and Maryland. Consumer Packaged Goods revenues, net of intersegment eliminations, made up 25% of total revenues during the three months ended September 30, 2023 as compared to 24% during the three months ended September 30, 2022.

Due to the vertically integrated nature of the business, the Company reviews its revenue at the Retail and Consumer Packaged Goods level while reviewing its operating results on a consolidated basis.

32

Nine Months Ended September 30, 2023 Compared with the Nine Months Ended September 30, 2022

Revenues, net of discounts for the Retail segment were $582,363, an increase of $17,412 or 3%, compared to the nine months ended September 30, 2022. The increase in Retail revenues, net of discounts, was primarily driven by the legalization of adult-use sales in New Jersey, which began on April 21, 2022, and the legalization of adult-use sales in Maryland, which began on July 1, 2023, partially offset by price compression.

Revenues, net of discounts, for the Consumer Packaged Goods Segment were $412,096 thousand, an increase of $43,404 thousand or 12%, compared to the nine months ended September 30, 2022. The increase in Consumer Packaged Goods revenues was primarily driven by the legalization of adult-use sales in New Jersey, which began on April 21, 2022, and the legalization of adult-use sales in Maryland, which began on July 1, 2023.

Intersegment eliminations associated with the Consumer Packaged Goods Segment were $218,137 thousand, an increase of $42,599 thousand or 24% compared to the nine months ended September 30, 2022. The increase in intersegment eliminations was driven by increased intercompany sales to Company-owned retail stores primarily in Pennsylvania and Maryland. Consumer Packaged Goods revenues, net of intersegment eliminations, made up 25% of total revenues during the nine months ended September 30, 2023 as compared to 25% during the nine months ended September 30, 2022.

Due to the vertically integrated nature of the business, the Company reviews its revenue at the Retail and Consumer Packaged Goods level while reviewing its operating results on a consolidated basis.

Drivers of Results of Operations

Revenue

The Company derives its revenue from two revenue streams: a Consumer Packaged Goods business in which it manufactures, sells and distributes its portfolio of Consumer Packaged Goods brands including Beboe, Dogwalkers, Dr. Solomon’s, Good Green, incredibles, and RYTHM, primarily to third-party customers; and a Retail business in which it sells finished goods sourced primarily from third-party cannabis manufacturers in addition to the Company’s own Consumer Packaged Goods products direct to the end consumer in its retail stores, as well as direct-to-consumer delivery where applicable by state law.

For the three and nine months ended September 30, 2023, revenue was contributed from Consumer Packaged Goods and Retail sales across California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.

Gross Profit

Gross profit is revenue less cost of goods sold. Cost of goods sold includes the costs directly attributable to product sales and includes amounts paid for finished goods, such as flower, edibles, and concentrates, as well as packaging and other supplies, fees for services and processing, and allocated overhead which includes allocations of rent, utilities and related costs. Cannabis costs are affected by various state regulations that limit the sourcing and procurement of cannabis product, which may create fluctuations in gross profit over comparative periods as the regulatory environment changes. Gross margin measures our gross profit as a percentage of revenue.

During the nine months ended September 30, 2023, the Company continued to focus on creating sustainable, profitable growth of the Company’s business within its current markets while considering strategic acquisition and partnership opportunities.

Total Expenses

Total expenses other than the cost of goods sold consist of selling costs to support customer relationships and marketing and branding activities. It also includes a significant investment in the corporate infrastructure required to support the Company’s ongoing business.

Retail selling costs generally correlate to revenue. As new stores begin operations, these stores generally experience higher selling costs as a percentage of revenue compared to more established stores, which experience a more constant rate of selling costs. As a percentage of sales, the Company expects selling costs to remain constant in the more established stores and increase in the newer stores as business continues to grow.

33

General and administrative expenses also include costs incurred at the Company’s corporate offices, primarily related to back office personnel costs, including salaries, incentive compensation, benefits, stock-based compensation and other professional service costs, and fair value adjustments on the Company's contingent consideration arrangements. The Company expects to continue to invest considerably in this area to support the business by attracting and retaining top-tier talent. Furthermore, the Company anticipates an increase in stock-based compensation expenses related to recruiting and hiring talent, along with legal and professional fees associated with being a publicly traded company in Canada and registered with the U.S. Securities and Exchange Commission.

Provision for Income Taxes

The Company is subject to income taxes in the jurisdictions in which it operates and, consequently, income tax expense is a function of the allocation of taxable income by jurisdiction and the various activities that impact the timing of taxable events. As the Company operates in the federally illegal cannabis industry, it is subject to the limitations of the U.S. Internal Revenue Code (“IRC”) Section 280E, under which taxpayers are only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E and a higher effective tax rate than most industries. Therefore, the effective tax rate can be highly variable and may not necessarily correlate to pre-tax income or loss.

Non-GAAP Measures

EBITDA, and Adjusted EBITDA are non-GAAP measures and do not have standardized definitions under GAAP. The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented.

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Net Income Before Non-Controlling Interest	$	10,807	$	10,148	$	33,902	$	64,565
Interest Income, net		(1,576)		(1,085)		(4,838)		(2,609)
Interest Expense, net		4,639		4,644		11,324		16,113
Provision For Income Taxes		34,526		32,969		93,927		102,440
Total Other Income		631		2,085		(23)		(14,933)
Depreciation and amortization		25,628		24,518		73,363		71,706
Earnings before interest, taxes, depreciation and    amortization (EBITDA) (non-GAAP measure)	$	74,655	$	73,279	$	207,655	$	237,282
Stock-based compensation, non-cash		7,215		7,878		20,835		19,362
Acquisition, transaction and other non-operating (income) costs		1,119		3,306		6,549		(26,405)
Adjusted EBITDA (non-GAAP measure)	$	82,989	$	84,463	$	235,039	$	230,239

34

Liquidity, Financing Activities During the Period, and Capital Resources

As of September 30, 2023, and December 31, 2022, the Company had total current liabilities of $149,882 thousand and $146,571 thousand, respectively, and cash and cash equivalents of $136,842 thousand and $177,682 thousand, respectively, to meet its current obligations. The Company had working capital of $170,299 thousand as of September 30, 2023, a decrease of $34,481 thousand as compared to December 31, 2022. This decrease in working capital was primarily driven by purchases of property, plant, and equipment as well as the repurchase of 2,500,000 Subordinate Voting Shares through the Company's share repurchase program.

The Company is an early-stage growth company, generating cash from revenues, deploying its capital reserves to acquire and develop assets capable of producing additional revenues and earnings over both the immediate and long term. Capital reserves are primarily being utilized for capital expenditures, facility improvements, strategic investment opportunities, product development and marketing, as well as customer, supplier, and investor and industry relations.

The Company takes a cautious approach in allocating its capital to maximize its returns while ensuring appropriate liquidity. Given the current uncertainty of the future economic environment, the Company has taken additional measures in monitoring and deploying its capital to minimize the negative impact on its current operations and expansion plans.

Cash Flows

Cash Used in Operating Activities, Investing and Financing Activities

Net cash provided by (used in) operating, investing and financing activities for the nine months ended September 30, 2023 and 2022, were as follows:

		Nine Months Ended September 30,
		2023		2022
		(in thousands)
Net Cash Provided by Operating Activities	$	153,872	$	88,220
Net Cash Used in Investing Activities	$	(187,444)	$	(161,168)
Net Cash Used in Financing Activities	$	(7,268)	$	(10,214)

Off-Balance Sheet Arrangements

As of September 30, 2023, the Company does not have any off-balance-sheet arrangements that have, or are reasonably likely to have, a current or future effect on the results of operations or financial condition of the Company, including, and without limitation, such considerations as liquidity and capital resources.

Changes in or Adoption of Accounting Practices

Refer to the discussion of recently adopted/issued accounting pronouncements under Part I, Item 1, Notes to Unaudited Interim Condensed Consolidated Financial Statements, Note 1—Overview and Basis of Presentation.

Critical Accounting Policies and Significant Judgments and Estimates

There were no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our 2022 Form 10-K.

35

ITEM 3. QUANTITAVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our market risk disclosures as set forth in Part II Item 7A of our 2022 Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company's management carried out an evaluation under the supervision and with the participation of the Company's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Based upon that evaluation, management concluded that our disclosure controls and procedures were effective as of September 30, 2023.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company's internal control over financial reporting during the third quarter of 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Control Systems

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, will be or have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

36

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is a party to a variety of legal proceedings that arise out of operations in the normal course of business. While the results of these legal proceedings cannot be predicted with certainty, the Company believes that the final outcome of these proceedings will not have a material adverse effect, individually or in the aggregate, on our results of operations or financial condition.

ITEM 1A. RISK FACTORS

For a discussion of our potential risks and uncertainties, see the information under the heading "Risk Factors" in our 2022 Form 10-K.

ITEM 2. UNREGISTERED SALE OF EQUITY SECURITIES, AND ISSUER PURCHASE OF EQUITY SECURITIES

Recent Sales of Unregistered Securities

Subordinate Voting Shares

On July 10, 2023, the Company issued 792,424 Subordinate Voting Shares as contingent consideration associated with the Company's July 2021 acquisition of Dharma Pharmaceuticals, LLC.

Multiple Voting Shares

None.

Super Voting Shares

None.

Recent Issuer Purchases of Equity Securities

(Dollars in thousands except per share amounts)
Period	Total Number of Shares Purchased		Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Program (1)		Approximate Dollar Value of Shares that may yet be Purchased Under the Program
July 1, 2023 through July 31, 2023	—	$	—	—	$	—
August 1, 2023 through August 31, 2023	—		—	—		—
September 1, 2023 through September 30, 2023	2,500,000		9.96	2,500,000		25,110
	2,500,000	$	9.96	2,500,000	$	25,110

(1) On September 5, 2023, the Company announced that its Board of Directors authorized the repurchase of up to 5%, or 10,486,951, of its Subordinate Voting Shares, over a 12-month period at a cost of up to $50,000 thousand. During the month of September 2023, the Company repurchased 2,500,000 Subordinate Voting Shares at an average price of $9.96 per share.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

37

ITEM 6. EXHIBITS

The following exhibits are filed with this report:

31.1	CERTIFICATE OF CHIEF EXECUTIVE OFFICER
31.2	CERTIFICATE OF CHIEF FINANCIAL OFFICER
32.1	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
32.2	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded with Inline XBRL File)

38

SIGNATURES

Pursuant to requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

GREEN THUMB INDUSTRIES INC.

/s/Benjamin Kovler

By: Benjamin Kovler

Title: Chief Executive Officer

Date: November 9, 2023

GREEN THUMB INDUSTRIES INC.

/s/Mathew Faulkner

By: Mathew Faulkner

Title: Chief Financial Officer

Date: November 9, 2023

39

EX-31.1

Exhibit 31.1

CERTIFICATE OF CHIEF EXECUTIVE OFFICER

I, Benjamin Kovler, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Green Thumb Industries Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

GREEN THUMB INDUSTRIES INC.

/s/Benjamin Kovler

By: Benjamin Kovler

Title: Chief Executive Officer

Date: November 9, 2023

EX-31.2

Exhibit 31.2

CERTIFICATE OF CHIEF FINANCIAL OFFICER

I, Mathew Faulkner, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Green Thumb Industries Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

GREEN THUMB INDUSTRIES INC.

/s/Mathew Faulkner

By: Mathew Faulkner

Title: Chief Financial Officer

Date: November 9, 2023

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Green Thumb Industries Inc. (the “Company”) on Form 10-Q for the three and nine months ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Benjamin Kovler, Chief Executive Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

GREEN THUMB INDUSTRIES INC.

/s/Benjamin Kovler

By: Benjamin Kovler

Title: Chief Executive Officer

Date: November 9, 2023

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Green Thumb Industries Inc. (the “Company”) on Form 10-Q for the three and nine months ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mathew Faulkner, Chief Financial Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

GREEN THUMB INDUSTRIES INC.

/s/Mathew Faulkner

By: Mathew Faulkner

Title: Chief Financial Officer

Date: November 9, 2023

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Nov. 01, 2023
Document Information [Line Items]
Document Type	10-Q
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Securities Act File Number	000-56132
Entity Registrant Name	GREEN THUMB INDUSTRIES INC.
Entity Central Index Key	0001795139
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, Address Line One	325 West Huron Street
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60654
Entity Tax Identification Number	98-1437430
City Area Code	312
Local Phone Number	471-6720
Entity Incorporation, State or Country Code	A1
Document Quarterly Report	true
Document Transition Report	false
Subordinate Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Subordinate Voting Shares
Super Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Super Voting Shares
Multiple Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Multiple Voting Shares
Forecast [Member] | Subordinate Voting Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		210,095,615
Forecast [Member] | Super Voting Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		226,690
Forecast [Member] | Multiple Voting Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		38,531

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Cash and Cash Equivalents	$ 136,842	$ 177,682
Accounts Receivable, Net	38,648	30,975
Income Tax Receivable	5,422	7,473
Inventories, Net	118,545	115,675
Prepaid Expenses	14,767	13,364
Other Current Assets	5,957	6,182
Total Current Assets	320,181	351,351
Property and Equipment, Net	692,667	557,873
Right of Use Assets, Net	240,036	242,357
Investments	77,335	74,169
Investment in Associates	25,355	25,508
Intangible Assets, Net	551,422	589,519
Goodwill	589,691	589,691
Deposits and Other Assets	2,525	3,060
TOTAL ASSETS	2,499,212	2,433,528
Current Liabilities:
Accounts Payable	22,507	18,423
Accrued Liabilities	86,469	86,971
Compensation Payable	11,498	13,476
Current Portion of Notes Payable	1,466	1,037
Current Portion of Lease Liabilities	11,818	10,906
Contingent Consideration Payable	0	11,400
Income Tax Payable	16,124	4,358
Total Current Liabilities	149,882	146,571
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion	250,017	249,281
Notes Payable, Net of Current Portion and Debt Discount	297,075	274,631
Contingent Consideration Payable	32,789	30,543
Warrant Liability	0	4,520
Deferred Income Taxes	62,550	62,550
TOTAL LIABILITIES	792,313	768,096
COMMITMENTS AND CONTINGENCIES
SHARE HOLDERS' EQUITY
Share Capital	1,702,344	1,663,557
Contributed Surplus	16,052	23,233
Deferred Share Issuances	12,973	36,211
Accumulated Deficit	(25,034)	(58,085)
Equity of Green Thumb Industries Inc.	1,706,335	1,664,916
Noncontrolling interests	564	516
TOTAL SHAREHOLDERS' EQUITY	1,706,899	1,665,432
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	2,499,212	2,433,528
Subordinate Voting Shares [Member]
SHARE HOLDERS' EQUITY
Share Capital
Multiple Voting Shares [Member]
SHARE HOLDERS' EQUITY
Share Capital
Super Voting Shares [Member]
SHARE HOLDERS' EQUITY
Share Capital

XML

Condensed Consolidated Balance Sheets (Parenthetical) - shares	Sep. 30, 2023	Dec. 31, 2022
Subordinate Voting Shares [Member]
Common Stock, Shares, Issued	210,042,431	206,991,275
Common Stock, Shares, Outstanding	210,042,431	206,991,275
Multiple Voting Shares [Member]
Common Stock, Shares, Issued	38,531	38,531
Common Stock, Shares, Outstanding	38,531	38,531
Super Voting Shares [Member]
Common Stock, Shares, Issued	226,690	251,690
Common Stock, Shares, Outstanding	226,690	251,690

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenues, Net of Discounts	$ 275,398	$ 261,194	$ 776,322	$ 758,105
Cost of Goods Sold, Net	(141,592)	(129,954)	(392,515)	(378,127)
Gross Profit	133,806	131,240	383,807	379,978
Expenses:
Selling, General, and Administrative	84,779	82,479	249,515	214,402
Total Expenses	84,779	82,479	249,515	214,402
Income From Operations	49,027	48,761	134,292	165,576
Other Income (Expense):
Other Income (Expense), net	(631)	(2,085)	23	14,933
Interest Income, net	1,576	1,085	4,838	2,609
Interest Expense, net	(4,639)	(4,644)	(11,324)	(16,113)
Total Other Income (Expense)	(3,694)	(5,644)	(6,463)	1,429
Income Before Provision for Income Taxes And Non-Controlling Interest	45,333	43,117	127,829	167,005
Provision For Income Taxes	34,526	32,969	93,927	102,440
Net Income Before Non-Controlling Interest	10,807	10,148	33,902	64,565
Net Income Attributable to Non-Controlling Interest	295	319	851	1,360
Net Income Attributable To Green Thumb Industries Inc.	$ 10,512	$ 9,829	$ 33,051	$ 63,205
Net Income per share - basic	$ 0.05	$ 0.04	$ 0.14	$ 0.27
Net Income per share - diluted	$ 0.05	$ 0.04	$ 0.14	$ 0.26
Weighted average number of shares outstanding - basic	239,459,783	237,002,873	238,248,852	236,546,078
Weighted average number of shares outstanding - diluted	240,289,959	237,804,799	239,827,112	237,872,595

XML

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Share Capital [Member]	Contributed Surplus (Deficit) [Member]	Deferred Share Issuance [Member]	Accumulated Earnings (Deficit) [Member]	Non-Controlling Interest [Member]
Beginning balance at Dec. 31, 2021	$ 1,619,478	$ 1,633,672	$ 21,245	$ 36,262	$ (70,063)	$ (1,638)
Noncontrolling interests adjustment for change in ownership		2,379	(17,735)			15,356
Issuance of shares under business combinations and investments	1,406	1,406
Shares issued as contingent consideration	13,111	13,111
Exercise of options and RSUs	2,684	9,327	(6,643)
Shares issued for settlement of business obligation	1,000	904	96
Stock based compensation	19,362		19,362
Distributions to limited liability company unit holders	(14,799)					(14,799)
Repurchase of Subordinate Voting Shares	0
Net income	64,565				63,205	1,360
Ending balance at Sep. 30, 2022	1,706,807	1,660,799	16,325	36,262	(6,858)	279
Beginning balance at Jun. 30, 2022	1,688,054	1,659,000	9,165	36,262	(16,687)	314
Exercise of options and RSUs	1,081	1,799	(718)
Stock based compensation	7,878		7,878
Distributions to third party and limited liability company unit holders	(354)					(354)
Net income	10,148				9,829	319
Ending balance at Sep. 30, 2022	1,706,807	1,660,799	16,325	36,262	(6,858)	279
Beginning balance at Dec. 31, 2022	1,665,432	1,663,557	23,233	36,211	(58,085)	516
Distribution of Contingent Consideration	12,524	12,524
Issuance of deferred shares		20,454		(20,454)
Indemnification of deferred shares associated with post acquisition costs	(2,784)			(2,784)
Exercise of options and RSUs	2,683	5,809	(3,126)
Shares issued for settlement of business obligation	0
Stock based compensation	20,835		20,835
Distributions to third party and limited liability company unit holders	(803)					(803)
Repurchase of Subordinate Voting Shares	(24,890)		(24,890)
Net income	33,902				33,051	851
Ending balance at Sep. 30, 2023	1,706,899	1,702,344	16,052	12,973	(25,034)	564
Beginning balance at Jun. 30, 2023	1,705,816	1,693,429	34,421	12,973	(35,546)	539
Distribution of Contingent Consideration	6,454	6,454
Exercise of options and RSUs	1,767	2,461	(694)
Stock based compensation	7,215		7,215
Distributions to third party and limited liability company unit holders	(270)					(270)
Repurchase of Subordinate Voting Shares	(24,890)		(24,890)
Net income	10,807				10,512	295
Ending balance at Sep. 30, 2023	$ 1,706,899	$ 1,702,344	$ 16,052	$ 12,973	$ (25,034)	$ 564

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOW FROM OPERATING ACTIVITIES
Net income attributable to Green Thumb Industries Inc.	$ 33,051	$ 63,205
Net income attributable to non-controlling interest	851	1,360
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	73,363	71,706
Amortization of operating lease assets	35,996	31,906
Loss on disposal of property and equipment	2,815	1,514
Impairment of long-lived property and equipment	285	0
Loss on equity method investment	952	2,382
Gain from lease modification	87	(3,330)
Stock based compensation	20,835	19,362
Decrease in fair value of investments	153	2,770
Increase (decrease) in fair value of contingent consideration	3,370	(29,005)
Decrease in fair value of warrants	(934)	(19,876)
Shares issued for settlement of business obligation	0	1,000
Gain on indemnification of deferred shares associated with post acquisition costs	(2,784)	0
Amortization of debt discount	7,128	6,837
Changes in operating assets and liabilities:
Accounts receivable, net	(7,673)	(8,691)
Inventories, net	(2,870)	(26,038)
Prepaid expenses and other current assets	(1,129)	(2,419)
Deposits and other assets	536	(22)
Accounts payable	4,084	(259)
Accrued liabilities	4,052	(4,021)
Operating lease liabilities	(32,114)	(27,599)
Income tax receivable and payable, net	13,818	7,438
NET CASH PROVIDED BY OPERATING ACTIVITIES	153,872	88,220
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment	(183,594)	(119,870)
Proceeds from disposal of property and equipment	319	112
Investments in securities and associates	(4,500)	(5,804)
Proceeds from equity investments and notes receivable	331	3,476
Settlement of acquisition consideration payable	0	(31,732)
Purchase of businesses, net of cash acquired	0	(7,350)
NET CASH USED IN INVESTING ACTIVITIES	(187,444)	(161,168)
CASH FLOW FROM FINANCING ACTIVITIES
Distributions to limited liability company unit holders	(803)	(14,799)
Contributions from unconsolidated subsidiaries	0	550
Repurchase of Subordinate Voting Shares	(24,890)	0
Proceeds from exercise of options and RSUs	2,683	2,684
Proceeds from issuance of notes payable	16,654	2,102
Principal repayment of notes payable	(912)	(751)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	(7,268)	(10,214)
CASH, CASH EQUIVALENTS:
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(40,840)	(83,162)
CASH, CASH EQUIVALENTS BEGINNING OF PERIOD	177,682	230,420
CASH, CASH EQUIVALENTS END OF PERIOD	136,842	147,258
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	15,564	13,699
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	(10,115)	(10,217)
Noncash increase in right of use asset	(5,599)	(72,714)
Noncash increase in lease liability	5,599	72,714
Mortgages associated with operating properties	0	7,350
Shares issued for purchase of noncontrolling interest	0	2,379
Issuance of shares associated with contingent consideration	12,524	13,111
Deferred share distributions	(20,454)	0
Issuance of shares under business combinations	0	1,406
Inventory	0	413
Accounts receivable	0	(153)
Prepaid assets	0	72
Property and equipment	0	738
Right of use assets	0	743
Identifiable intangible assets	0	10,359
Goodwill	0	11,736
Deposits and other assets	0	12
Liabilities assumed	0	(712)
Lease liabilities	0	(743)
Noncontrolling interests	0	17,735
Contingent liabilities	0	(200)
Equity interests issued	0	(3,785)
Fair value of previously held equity interest	0	(14,500)
Deferred income taxes	0	991
Settlement of noncontrolling interests	0	(15,356)
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed), Total	0	7,350
Decrease in fair value of investments	153	16,889
Increase in fair value of equity method investments	0	(14,119)
TOTAL DECREASE IN FAIR VALUE OF INVESTMENTS	$ 153	$ 2,770

XML

Overview and Basis of Presentation

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Overview and Basis of Presentation

1. Overview and Basis of Presentation

(a) Description of Business

Green Thumb Industries Inc. (“Green Thumb,” the “Company,” “we” or “us”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail cannabis stores. The Company also owns and operates retail cannabis stores that include a rapidly growing national chain named RISE, which sell our products and third-party products. As of September 30, 2023, Green Thumb has revenue in fifteen markets (California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately 4,400 people and serves millions of patients and customers annually.

The Company’s registered office is located at 250 Howe Street, 20th Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters are at 325 W. Huron St., Suite 700, Chicago, IL 60654.

(b) Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, (the “2022 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.

(c) Significant Accounting Policies

There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2022 Form 10-K.

(d) Earnings per Share

Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of September 30, 2023, the Company had 10,229,895 options, 3,499,193 restricted stock units and 3,734,555 warrants outstanding. As of September 30, 2022, the Company had 9,725,907 options, 952,753 restricted stock units and 3,835,278 warrants outstanding.

1. Overview and Basis of Presentation (Continued)

(d) Earnings per Share (Continued)

In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended September 30, 2023, the computation of diluted earnings per share included 211,651 options and 618,525 restricted stock units. For the nine months ended September 30, 2023, the computation of diluted earnings per share included 153,215 options and 1,425,045 restricted stock units. There were no dilutive warrants during the three and nine months ended September 30, 2023 as the strike price was greater than the average stock price for the period. For the three months ended September 30, 2022, the computation of diluted earnings per share included 697,800 options, 57,128 restricted stock units and 46,998 warrants. For the nine months ended September 30, 2022, the computation of diluted earnings per share included 968,322 options, 226,564 restricted stock units and 131,631 warrants. For the three and nine months ended September 30, 2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,349,064 and 3,198,625, respectively. For the three and nine months ended September 30, 2022, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,052,822 and 2,192,896, respectively.

(e) Recently Issued Accounting Standards

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

XML

Inventories

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Inventories

2. INVENTORIES

The Company’s inventories include the following at September 30, 2023 and December 31, 2022:

		September 30, 2023		December 31, 2022
		(in thousands)
Raw Material	$	1,120	$	3,070
Packaging and Miscellaneous		10,756		9,847
Work in Process		45,072		57,287
Finished Goods		65,707		49,268
Reserve for Obsolete Inventory		(4,110)		(3,797)
Total Inventories, Net	$	118,545	$	115,675

XML

Property and Equipment

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment

3. PROPERTY AND EQUIPMENT

At September 30, 2023 and December 31, 2022, property and equipment consisted of the following:

		September 30, 2023		December 31, 2022
		(in thousands)
Buildings and Improvements	$	340,641	$	176,874
Equipment, Computers and Furniture		158,327		122,568
Leasehold Improvements		186,354		135,524
Land Improvements		995		847
Capitalized Interest		30,517		16,934
Total Property and Equipment		716,834		452,747
Less: Accumulated Depreciation		(113,507)		(80,702)
Property and Equipment, net		603,327		372,045
Land		33,725		29,106
Assets Under Construction		55,615		156,722
Property and Equipment, net	$	692,667	$	557,873

Assets under construction represent construction in progress related to both cultivation and retail store facilities not yet completed or otherwise not ready for use.

Depreciation expense for the three and nine months ended September 30, 2023 totaled $12,885 thousand and $35,266 thousand, respectively, of which $8,298 thousand and $23,348 thousand, respectively, is included in cost of goods sold. Depreciation expense for the three and nine months ended September 30, 2022 totaled $9,695 thousand and $26,844 thousand, respectively, of which $6,393 thousand and $17,357 thousand, respectively, is included in cost of goods sold.

XML

Intangible Assets And Goodwill

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

4. INTANGIBLE ASSETS AND GOODWILL

(a) Intangible Assets

Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

At September 30, 2023 and December 31, 2022, intangible assets consisted of the following:

		September 30, 2023						December 31, 2022
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	146,739	$	513,977	$	660,716	$	113,800	$	546,916
Trademarks		41,511		12,655		28,856		41,511		10,486		31,025
Customer Relationships		24,438		16,054		8,384		24,438		13,435		11,003
Non-Competition Agreements		2,565		2,360		205		2,565		1,990		575
Total Intangible Assets	$	729,230	$	177,808	$	551,422	$	729,230	$	139,711	$	589,519

The Company recorded amortization expense for the three and nine months ended September 30, 2023 of $12,743 thousand and $38,097 thousand, respectively. The Company recorded amortization for the three and nine months ended September 30, 2022 of $14,823 thousand and $44,862 thousand, respectively.

The following table outlines the estimated annual amortization expense related to intangible assets as of September 30, 2023:

		Estimated Amortization
Year Ending December 31,		(in thousands)
Remainder of 2023	$	12,744
2024		50,392
2025		50,294
2026		47,332
2027		46,803
2028 and Thereafter		343,857
	$	551,422

As of September 30, 2023, the weighted average amortization period remaining for intangible assets was 11.60 years.

(b) Goodwill

At September 30, 2023 and December 31, 2022 the balances of goodwill, by segment, consisted of the following:

		Retail		Consumer Packaged Goods		Total
		(in thousands)
As of December 31, 2022	$	273,802	$	315,889	$	589,691
As of September 30, 2023	$	273,802	$	315,889	$	589,691

XML

Investments

9 Months Ended

Sep. 30, 2023

Investments [Abstract]

Investments

5. INVESTMENTS

As of September 30, 2023 and December 31, 2022, the Company held various equity interests in cannabis related companies as well as investments in note receivable instruments that had a combined fair value of $77,335 thousand and $74,169 thousand as of each period end, respectively. The Company measures its investments that do not have readily determinable fair value at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company performs an assessment on a quarterly basis to determine whether triggering events for impairment exist and to identify any observable price changes.

The following table summarizes the changes in the Company’s investments during the nine months ended September 30, 2023 and year ending December 31, 2022:

		September 30, 2023		December 31, 2022
	(in thousands)
Beginning	$	74,169	$	94,902
Additions		3,700		5,444
Disposals		(331)		(3,571)
Fair value adjustment		(153)		(22,606)
Transfers and other		(50)		—
Ending	$	77,335	$	74,169

During the three and nine months ended September 30, 2023, the Company recorded fair value gains (losses), net of interest income of $775 thousand and $(153) thousand, respectively. The fair value gains (losses) associated with the Company's equity investments in the amount of $724 thousand and $(410) thousand as of the three and nine months ended September 30, 2023, respectively, was recorded within other income (expense) on the Company's unaudited interim condensed consolidated statements of operations. The interest income portion associated with the Company's note receivable investments in the amount of $51 thousand and $257 thousand as of the three and nine months ended September 30, 2023, respectively was recorded within interest income on the unaudited interim condensed consolidated statements of operations.

(a) Equity Investments

As of September 30, 2023 and December 31, 2022, the Company held equity investments in publicly traded entities which have readily determinable fair values, which are classified as Level 1 investments, of $2,094 thousand and $2,535 thousand, respectively. During the three and nine months ended September 30, 2023, the Company recorded net gains (losses) on the change in fair value of such investments of $724 thousand and $(410) thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. During the three and nine months ended September 30, 2022, the Company recorded net gains (losses) on the change in fair value of such investments of $124 thousand and $(14,169) thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. During the nine months ended September 30, 2023 and 2022, the Company received proceeds from the sale of such investments of $31 thousand and $2,393 thousand, respectively. These investments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

As of September 30, 2023 and December 31, 2022, the Company held equity investments in privately held entities that did not have readily determinable fair values, which are classified as Level 3 investments, of $42,330 thousand and $40,330 thousand, respectively. For the three and nine months ended September 30, 2023, there were no gains or losses on the change in fair value of such investments. During the three and nine months ended September 30, 2022, the Company recorded net gains (losses) on the change in fair value of such investments of $(295) thousand and $182 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. There were no sales of these investments during these periods. These investments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

5. INVESTMENTS (Continued)

(a) Equity Investments (Continued)

Unrealized gains and (losses) recognized on equity investments held during the three and nine months ended September 30, 2023 were $660 thousand and $(350) thousand, respectively. Unrealized losses recognized on equity investments held during the three and nine months ended September 30, 2022 were $137 thousand and $(13,825) thousand, respectively.

(b) Note Receivable Instruments

The Company has made multiple investments in various note receivable instruments, including note receivable instruments with conversion features.

The Company held note receivable instruments, which were classified as a Level 1 investment as they represent public debt of a publicly traded entity, and had a fair value of $22,214 thousand as of September 30, 2023 and December 31, 2022. During the three and nine months ended September 30, 2023, there were no gains or (losses) on the change in fair value of such investments. For the three and nine months ended September 30, 2022, the Company recorded net gains (losses) on the change in fair value of such investments of $418 thousand and $(236) thousand, respectively within other income (expense) on the unaudited interim condensed consolidated statements of operations. The note receivable instruments have a stated interest rate of 13% and a maturity date of April 30, 2025. These note receivable instruments did not contain conversion features and are currently classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

As of September 30, 2023 and December 31, 2022, the Company held note receivable instruments which were classified as Level 3 investments as they represent loans provided to privately held entities that do not have readily determinable fair values. The note receivable instruments had a combined fair value of $10,697 thousand and $9,090 thousand, respectively, with stated interest ranging between 0.91% and 10% and terms between 9 months to five years. During the three and nine months ended September 30, 2023, there were no gains or (losses) recorded on the change in fair value of such investments, however, the company recorded accrued interest of $51 thousand and $257 thousand, respectively, within interest income on the unaudited interim condensed consolidated statements of operations. During the three and nine months ended September 30, 2022, the Company recorded net losses on the change in fair value of such investments of $0 thousand and $3,145 thousand, respectively, within other income (expense) and accrued interest of $185 thousand and $479 thousand, respectively, within interest income on the unaudited interim condensed consolidated statements of operations. These note receivable instruments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

See Note 13 - Fair Value Measurements for additional details.

XML

Leases

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Leases

6. LEASES

(a) Operating Leases

The Company has operating leases for its retail stores and processing and cultivation facilities located throughout the U.S., as well as corporate office space located in Illinois. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date.

All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for fixed and variable non-lease components, such as taxes, insurance and maintenance. The Company accounts for each real estate lease and the related non-lease components together as a single component.

The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. For the three and nine months ended September 30, 2023, the Company recorded operating lease expense of $11,628 thousand and $35,996 thousand, respectively compared to operating lease expense of $11,884 thousand and $31,906 thousand for the three and nine months ended September 30, 2022, respectively.

Other information related to operating leases as of September 30, 2023 and December 31, 2022 were as follows:

	September 30, 2023	December 31, 2022
Weighted average remaining lease term (years)	11.98	11.64
Weighted average discount rate	12.41%	12.42%

Maturities of lease liabilities for operating leases as of September 30, 2023 were as follows:

		Maturities of Lease Liability
Year Ending December 31,		Third Party		Related Party		Total
		(in thousands)
Remainder of 2023	$	10,669	$	143	$	10,812
2024		43,250		437		43,687
2025		41,114		343		41,457
2026		40,409		350		40,759
2027		40,793		357		41,150
2028 and Thereafter		358,013		1,728		359,741
Total Lease Payments		534,248		3,358		537,606
Less: Interest		(274,503)		(1,268)		(275,771)
Present Value of Lease Liability	$	259,745	$	2,090	$	261,835

(b) Related Party Operating Leases

The Company has leasing arrangements that are related party transactions, including for certain facilities in Maryland, Massachusetts and Nevada. Wendy Berger, a director of the Company, is a principal of WBS Equities, LLC, which is the Manager of Mosaic Real Estate, LLC, and owns the facilities leased by the Company. Additionally, Mosaic Real Estate, LLC is indirectly owned in part by Ms. Berger (through the Wendy Berger 1998 Revocable Trust), Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (through KP Capital, LLC), and Anthony Georgiadis, the President and a director of the Company (through Three One Four Holdings, LLC). The terms of these leases range from 7 years to 15 years. For the three and nine months ended September 30, 2023, the Company recorded lease expense of $139 thousand and $415 thousand, respectively, compared to lease expense of $296 thousand and $886 thousand for the three and nine months ended September 30, 2022, respectively.

XML

Notes Payable

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Notes Payable

. NOTES PAYABLE

At September 30, 2023 and December 31, 2022, notes payable consisted of the following:

		September 30, 2023		December 31, 2022
		(in thousands)
Charitable Contributions1	$	400	$	764
Private placement debt dated April 30, 20212		244,623		237,795
Mortgage notes3		53,518		37,109
Total notes payable		298,541		275,668
Less: current portion of notes payable		(1,466)		(1,037)
Notes payable, net of current portion	$	297,075	$	274,631

1 In connection with acquisitions completed in 2017 and 2019, the Company is required to make quarterly charitable contributions of $50 thousand through October 2024 and annual charitable contributions of $250 thousand through May 2024, respectively. The net present value of these required payments has been recorded as a liability with interest rates ranging between 2.17% - 7.00%.

2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in a total amount of $249,934 thousand with an interest rate of 7.00%, maturing on April 30, 2025. The April 30, 2021 Notes were issued at a discount, the carrying value of which was $5,311 thousand and $12,139 thousand as of September 30, 2023 and December 31, 2022, respectively.

3 Mortgage notes with an initial value of $55,017 thousand and $38,292 thousand, respectively, were issued by the Company in connection with various operating properties, and were recorded at such gross value as of September 30, 2023 and December 31, 2022. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00% and 9.50%. The mortgage notes were issued at a discount, the carrying value of which was $237 thousand and $437 thousand, respectively, and are presented net of principal payments of $1,262 thousand and $746 thousand as of September 30, 2023 and December 31, 2022, respectively.

(b) Related Parties

A portion of the April 30, 2021 Notes are held by related parties as well as unrelated third-party lenders at a percentage of approximately 1% and 99%, respectively. The related parties consist of Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (held through KP Capital, LLC and Outsiders Capital, LLC); Andrew Grossman, the Executive Vice President of Capital Markets of the Company (held through AG Funding Group, LLC); Anthony Georgiadis, the President and a director of the Company (held through Three One Four Holdings, LLC and ABG, LLC).

XML

Warrants

9 Months Ended

Sep. 30, 2023

Warrants and Rights Note Disclosure [Abstract]

Warrants

8. WARRANTS

As part of the terms of the Company's issuance of the April 30, 2021 Notes, as well as other financing arrangements, the Company issued warrants to related parties, as well as unrelated third parties, which allow the holders to purchase Subordinate Voting Shares at an exercise price determined at the time of issuance.

The following table summarizes the number of warrants outstanding as of September 30, 2023 and December 31, 2022:

	Liability Classified							Equity Classified
	Number of Shares			Weighted Average Exercise Price (C$)		Weighted Average Remaining Contractual Life		Number of Shares			Weighted Average Exercise Price (USD)		Weighted Average Remaining Contractual Life
Balance as of December 31, 2022		1,997,208	C$		18.03		1.50		1,737,347	$		31.83		3.38
Balance as of September 30, 2023		1,997,208	C$		18.03		0.75		1,737,347	$		31.83		2.63

(a) Liability Classified Warrants Outstanding

The following table summarizes the fair value of the liability classified warrants at September 30, 2023 and December 31, 2022:

				Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		September 30, 2023		December 31, 2022		Change
				(in thousands)
Private Placement Financing Warrants Issued May 2019	C$19.39		1,606,533	$	1,820	$	3,125	$	(1,305	)
Modification Warrants Issued November 2019	C$12.04		316,947		1,434		1,139		295
Additional Modification Warrants Issued May 2020	C$14.03		73,728		332		256		76
Totals			1,997,208	$	3,586	$	4,520	$	(934	)

During the three and nine months ended September 30, 2023 and 2022, the Company recorded a loss of $1,329 thousand, a gain of $934 thousand, a loss of $1,896 thousand and a gain of $19,876 thousand, respectively, on the change in the fair value of the warrant liability within other income (expense) on the unaudited interim condensed consolidated statements of operations. As of September 30, 2023, the warrant liability was classified as a current liability, and recorded within accrued liabilities on the unaudited interim condensed consolidated balance sheets.

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 13 - Fair Value Measurements for additional details):

	September 30,	December 31,
Significant Assumptions	2023	2022
Volatility	59.08% - 76.33%	70.44% - 78.21%
Remaining Term	0.64-1.64 years	1.39 - 2.39 years
Risk Free Rate	4.83%	3.82% - 4.07%

8. WARRANTS (Continued)

(b) Equity Classified Warrants Outstanding

The Company's equity classified warrants were recorded at fair value at each respective date of issuance. Equity classified warrants are not remeasured at fair value on a recurring basis and are carried at their issuance date fair value. The following table summarizes the carrying amounts of the Company's equity classified warrants at September 30, 2023 and December 31, 2022:

					Issuance Date Fair Value
			Warrants		September 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price		Outstanding		2023		2022
					(in thousands)
Mortgage Warrants Issued June 2020	$	9.10		35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$	32.68		1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$	30.02		243,303		2,616		2,616
Totals				1,737,347	$	25,056	$	25,056

The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date:

Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%

XML

Share Capital

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Share Capital

9. SHARE CAPITAL

Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares, are classified as equity. Incremental costs directly attributable to the issuance of common shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the applicable vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes.

(a) Authorized

The Company has the following classes of share capital, with each class having no par value:

(i) Subordinate Voting Shares

The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares. During the three months ended September 30, 2023, shareholders of the Company converted 25,000 Multiple Voting Shares into 2,500,000 Subordinate Voting Shares.

(ii) Multiple Voting Shares

Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. At September 30, 2023, the Company had 38,531 issued and outstanding Multiple Voting Shares, which convert into 3,853,100 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple Voting Shares. During the three months ended September 30, 2023, shareholders of the Company converted 25,000 Super Voting Shares into 25,000 Multiple Voting Shares and 25,000 Multiple Voting Shares into 2,500,000 Subordinate Voting Shares.

(iii) Super Voting Shares

Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for one Multiple Voting Share. At September 30, 2023, the Company had 226,690 issued and outstanding Super Voting Shares which ultimately convert into 22,669,000 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Super Voting Shares. During the three months ended September 30, 2023, shareholders of the Company converted 25,000 Super Voting Shares into 25,000 Multiple Voting Shares.

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2023	206,991,275	38,531	251,690
Distribution of contingent consideration	1,614,871	—	—
Distribution of deferred shares	680,089	—	—
Issuance of shares upon exercise of options	365,521	—	—
Issuances of shares upon vesting of RSUs	390,676	—	—
Repurchase of Subordinate Voting Shares	(2,500,001)	—	—
Exchange of shares	2,500,000	—	(25,000)
As at September 30, 2023	210,042,431	38,531	226,690

9. SHARE CAPITAL (Continued)

(b) Issued and Outstanding (Continued)

(i) Distribution of Deferred Shares

As part of the consideration exchanged for certain acquisitions completed throughout 2021, the Company deferred the distribution of Subordinate Voting Shares to secure the Company's indemnification rights associated with post-acquisition costs. The following table summarizes the activity during the nine months ended September 30, 2023:

Related Acquisition	As at December 31, 2022	Distributed Shares	Cancelled Shares	As at September 30, 2023
Liberty Compassion, Inc.	214,768	(214,768)	—	—
Dharma Pharmaceuticals, LLC	229,878	(229,878)	—	—
Mobley Pain Management and Wellness Center, LLC and Canwell Processing, LLC	264,760	(12,305)	(84,122)	168,333
GreenStar Herbals, Inc.	161,306	(161,306)	—	—
Maryland Health and Wellness Center, Inc.	61,832	(61,832)	—	—
LeafLine Industries, LLC	386,002	—	—	386,002
Total	1,318,546	(680,089)	(84,122)	554,335

As of September 30, 2023 and December 31, 2022, the Company held deferred shares in the amount of $12,973 thousand and $36,211 thousand, respectively. In accordance with the relevant acquisition agreement, a portion of the outstanding deferred shares were cancelled in order to indemnify the Company for post-acquisition costs. As the cancellation of the deferred shares occurred outside of the purchase price allocation measurement period (generally one year from the acquisition date), the Company recorded a gain of $2,784 thousand within selling general and administrative expenses on the Company's unaudited interim condensed consolidated statements of operations during the nine months ended September 30, 2023.

(ii) Distribution of Contingent Consideration

Dharma Pharmaceuticals, LLC

In connection with the Company's 2021 acquisition of Dharma Pharmaceuticals, LLC (“Dharma”), the purchase agreement included contingent consideration of up to $65,000 thousand in Subordinate Voting Shares of Green Thumb, dependent upon the successful opening of up to five retail stores in the Virginia area within the first three years following the signing of the agreement and the legal sale of adult-use cannabis in a retail store by January 1, 2025. On June 1, 2023 and July 10, 2023, the Company issued 822,447 and 792,424 Subordinate Voting Shares, respectively, to the former owners of Dharma in connection with the successful opening of the fourth and fifth retail stores in Virginia. The shares had a combined fair value of $12,524 thousand at the date of issuance.

As of September 30, 2023 and December 31, 2022, the total estimated fair value of the contingent consideration associated with the acquisition of Dharma, which was valued based on the probability weighting of potential payouts, was $32,789 thousand, and $41,943 thousand, respectively. As of December 31, 2022, $11,400 thousand of the total value of the contingent consideration was included within current liabilities on the Company's unaudited interim condensed consolidated balance sheets. As of September 30, 2023, no portion of the contingent consideration was included within current liabilities on the Company's unaudited interim condensed consolidated balance sheets.

(iii) Repurchase of Subordinate Voting Shares

On September 5, 2023, the Company announced that its Board of Directors authorized the Company to repurchase up to 5%, or 10,486,951 of its Subordinate Voting Shares over a 12-month period at an aggregate cost of up to $50,000 thousand. During the month of September 2023, the Company repurchased 2,500,000 Subordinate Voting Shares at an average price of $9.96 per share.

9. SHARE CAPITAL (Continued)

(c) Stock-Based Compensation

The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity.

In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1 and Amendment No. 2 thereto (as amended, the “Plan”). The maximum number of Restricted Stock Units (“RSUs”) and options outstanding under the Plan at any time shall not exceed 10% of the then issued and outstanding shares on an as-converted basis.

The Company recognizes compensation expense for RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized.

Option and RSU awards generally vest over three years, and options typically have a life of five to ten years. Option grants under the Plan are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant.

Stock option activity is summarized as follows:

	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life
Balance as of December 31, 2022	9,577,947	$12.71	4.80
Granted	2,321,729	7.72	6.50
Exercised	(365,521)	7.34
Forfeited	(1,304,260)	12.25
Balance as of September 30, 2023	10,229,895	$11.82	4.60
Vested	5,341,985	$17.24
Exercisable as of September 30, 2023	3,566,406	$7.99	2.84

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2023 and the year ended December 31, 2022, using the following ranges of assumptions:

	September 30,	December 31,
	2023	2022
Risk-free interest rate	3.06% - 4%	1.18% - 3.54%
Expected dividend yield	0%	0%
Expected volatility	64%	60% - 64%
Expected option life	3.5 – 4.5 years	3 – 4.5 years

As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.

9. SHARE CAPITAL (Continued)

(c) Stock-Based Compensation (Continued)

The following table summarizes the number of unvested RSU awards as of September 30, 2023 and December 31, 2022 and the changes during the nine months ended September 30, 2023:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2022	947,502	$	17.91
Granted	3,307,909		7.67
Forfeited	(365,542)		10.83
Vested	(390,676)		15.50
Unvested Shares at September 30, 2023	3,499,193	$	9.24

The stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Stock options expense	$	4,009	$	6,003	$	12,795	$	12,985
Restricted Stock Units		3,206		1,875		8,040		6,377
Total Stock Based Compensation Expense	$	7,215	$	7,878	$	20,835	$	19,362

As of September 30, 2023, $45,048 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.05 years.

XML

Income Tax Expense

9 Months Ended

Sep. 30, 2023

Income Tax Disclosure [Abstract]

Income Tax Expense

10. INCOME TAX EXPENSE

The following table summarizes the Company’s income tax expense and effective tax rates for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
Income before Income Taxes	$	45,333	$	43,117	$	127,829	$	167,005
Income Tax Expense		34,526		32,969		93,927		102,440
Effective Tax Rate		76.2%		76.5%		73.5%		61.3%

The effective tax rates for the three and nine months ended September 30, 2023 and 2022 were based on the Company’s forecasted annualized effective tax rates and were adjusted for discrete items that occurred within the periods presented.

Due to its cannabis operations, the Company is subject to the limitations of the U.S. Internal Revenue Code of 1986, as amended (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income and provides for effective tax rates that are well in excess of statutory tax rates.

Taxes paid during the nine months ended September 30, 2023 and 2022 were $80,398 thousand and $95,307 thousand, respectively.

XML

Other Income (Expense)

9 Months Ended

Sep. 30, 2023

Other Income and Expenses [Abstract]

Other Income (Expense)

11. OTHER INCOME (EXPENSE)

For the three and nine months ended September 30, 2023 and 2022 other income (expense) was comprised of the following:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	724	$	247	$	(410)	$	(17,368)
Fair value adjustments on equity method investments		—		—		—		14,119
Fair value adjustments on warrants issued		(1,329)		(1,896)		934		19,876
Earnings (loss) from equity method investments		(202)		(441)		(952)		(2,382)
Other		176		5		451		688
Total Other Income (Expense)	$	(631)	$	(2,085)	$	23	$	14,933

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12. COMMITMENTS AND CONTINGENCIES

The Company is subject to lawsuits, investigations and other claims related to employment, commercial and other matters that arise out of operations in the normal course of business. Periodically, the Company reviews the status of each significant matter and assesses the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably estimated, such amount is recognized in other liabilities.

Contingent liabilities are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period and are discounted to present value where the effect is material. The Company performs evaluations to identify contingent liabilities for contracts. Contingent consideration is measured upon acquisition and is estimated using probability weighting of potential payouts. Subsequent changes in the estimated contingent consideration from the final purchase price allocation are recognized in the Company’s unaudited interim condensed consolidated statements of operations.

(a) Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, sanctions, restrictions on its operations, or losses of permits that could result in the Company ceasing operations in that specific state or local jurisdiction. The Company may be subject to regulatory fines, penalties, or restrictions in the future as cannabis and other regulations continue to evolve and are subject to differing interpretations.

(b) Claims and Litigation

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. The following is an update to the status of previously disclosed matters as of September 30, 2023:

Cresco Labs New York, LLC and Cresco Labs LLC (“Plaintiffs”) filed an amended complaint against one of the Company’s subsidiaries, Fiorello Pharmaceuticals, Inc. (“Defendant”) on November 20, 2018, in the Supreme Court of the State of New York, alleging Defendant breached the parties’ Equity Purchase Agreement Letter of Intent (“LOI”) relating to the acquisition of Defendant by Plaintiffs. As of September 30, 2023, the Company believed the potential exposure associated with the complaint was de minimis and reduced the estimated liability accordingly. Subsequently, on October 18, 2023, all pending motions were withdrawn and Plaintiffs' claims were dismissed with prejudice.

At September 30, 2023, there were no other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s consolidated operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest.

(c) Construction Commitments

As of September 30, 2023, the Company held approximately $7,100 thousand of open construction commitments to contractors on work being performed.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2023

Disclosure Text Block Supplement [Abstract]

Fair Value Measurements

13. FAIR VALUE MEASUREMENTS

The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3 – Inputs for the asset or liability that are not based on observable market data.

(a) Financial Instruments

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, investments, accounts payable and accrued liabilities, notes payable, warrant liability, and contingent consideration payable.

It was not practicable to estimate the fair value of the Company's long-term notes payable, which consist of charitable contributions, private placement debt and mortgage notes, since there were no quoted prices or active trading markets. The carrying amount of notes payable at September 30, 2023 and December 31, 2022 was $298,541 thousand and $275,668 thousand, which includes $1,466 thousand and $1,037 thousand, respectively, of short-term debt due within one year.

Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements. The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:

		As of September 30, 2023
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	136,842	$	—	$	—	$	136,842
Investments		24,308		—		53,027		77,335
Contingent Consideration Payable		—		—		(32,789)		(32,789)
Warrant Liability		—		—		(3,586)		(3,586)
	$	161,150	$	—	$	16,652	$	177,802

		As of December 31, 2022
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	177,682	$	—	$	—	$	177,682
Investments		24,749		—		49,420		74,169
Contingent Consideration Payable		—		—		(41,943)		(41,943)
Warrant Liability		—		—		(4,520)		(4,520)
	$	202,431	$	—	$	2,957	$	205,388

XML

Segment Reporting

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Segment Reporting

14. SEGMENT REPORTING

The Company operates in two segments: the cultivation, production and sale of cannabis products to retail stores (“Consumer Packaged Goods”) and retailing of cannabis to patients and consumers (“Retail”). The Company does not allocate operating expenses to these business units, nor does it allocate specific assets. Additionally, the Chief Operating Decision Maker does not review total assets or net income (loss) by segments; therefore, such information is not presented below.

The below table presents revenues by type for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	205,441	$	199,632	$	582,363	$	564,951
Consumer Packaged Goods		150,425		127,676		412,096		368,692
Intersegment Eliminations		(80,468)		(66,114)		(218,137)		(175,538)
Total Revenues, Net of Discounts	$	275,398	$	261,194	$	776,322	$	758,105
Depreciation and Amortization
Retail	$	9,598	$	9,921	$	27,539	$	29,881
Consumer Packaged Goods		16,030		14,597		45,824		41,825
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	25,628	$	24,518	$	73,363	$	71,706
Income Taxes
Retail	$	18,551	$	18,589	$	50,890	$	58,460
Consumer Packaged Goods		15,975		14,380		43,037		43,980
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	34,526	$	32,969	$	93,927	$	102,440

Goodwill assigned to the Consumer Packaged Goods segment as of September 30, 2023 and December 31, 2022 was $315,889 thousand and $315,889 thousand, respectively. Intangible assets, net assigned to the Consumer Packaged Goods segment as of September 30, 2023 and December 31, 2022 was $266,884 thousand and $286,922 thousand, respectively.

Goodwill assigned to the Retail segment as of September 30, 2023 and December 31, 2022 was $273,802 thousand and $273,802 thousand, respectively. Intangible assets, net assigned to the Retail segment as of September 30, 2023 and December 31, 2022 was $284,538 thousand and $302,597 thousand, respectively.

The Company’s assets are aggregated into two reportable segments (Retail and Consumer Packaged Goods). For the purposes of testing goodwill, Green Thumb has identified two reporting units which align with our reportable segments (Retail and Consumer Packaged Goods). All revenues are derived from customers domiciled in the United States and all assets are located in the United States.

XML

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Preparation

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, (the “2022 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.

Significant Accounting Policies

Significant Accounting Policies

There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2022 Form 10-K.

Earnings per Share

Earnings per Share

Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of September 30, 2023, the Company had 10,229,895 options, 3,499,193 restricted stock units and 3,734,555 warrants outstanding. As of September 30, 2022, the Company had 9,725,907 options, 952,753 restricted stock units and 3,835,278 warrants outstanding.

1. Overview and Basis of Presentation (Continued)

(d) Earnings per Share (Continued)

In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended September 30, 2023, the computation of diluted earnings per share included 211,651 options and 618,525 restricted stock units. For the nine months ended September 30, 2023, the computation of diluted earnings per share included 153,215 options and 1,425,045 restricted stock units. There were no dilutive warrants during the three and nine months ended September 30, 2023 as the strike price was greater than the average stock price for the period. For the three months ended September 30, 2022, the computation of diluted earnings per share included 697,800 options, 57,128 restricted stock units and 46,998 warrants. For the nine months ended September 30, 2022, the computation of diluted earnings per share included 968,322 options, 226,564 restricted stock units and 131,631 warrants. For the three and nine months ended September 30, 2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,349,064 and 3,198,625, respectively. For the three and nine months ended September 30, 2022, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,052,822 and 2,192,896, respectively.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Summary of inventory

The Company’s inventories include the following at September 30, 2023 and December 31, 2022:

		September 30, 2023		December 31, 2022
		(in thousands)
Raw Material	$	1,120	$	3,070
Packaging and Miscellaneous		10,756		9,847
Work in Process		45,072		57,287
Finished Goods		65,707		49,268
Reserve for Obsolete Inventory		(4,110)		(3,797)
Total Inventories, Net	$	118,545	$	115,675

XML

Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

At September 30, 2023 and December 31, 2022, property and equipment consisted of the following:

		September 30, 2023		December 31, 2022
		(in thousands)
Buildings and Improvements	$	340,641	$	176,874
Equipment, Computers and Furniture		158,327		122,568
Leasehold Improvements		186,354		135,524
Land Improvements		995		847
Capitalized Interest		30,517		16,934
Total Property and Equipment		716,834		452,747
Less: Accumulated Depreciation		(113,507)		(80,702)
Property and Equipment, net		603,327		372,045
Land		33,725		29,106
Assets Under Construction		55,615		156,722
Property and Equipment, net	$	692,667	$	557,873

XML

Intangible Assets And Goodwill (Tables)

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets

At September 30, 2023 and December 31, 2022, intangible assets consisted of the following:

		September 30, 2023						December 31, 2022
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	146,739	$	513,977	$	660,716	$	113,800	$	546,916
Trademarks		41,511		12,655		28,856		41,511		10,486		31,025
Customer Relationships		24,438		16,054		8,384		24,438		13,435		11,003
Non-Competition Agreements		2,565		2,360		205		2,565		1,990		575
Total Intangible Assets	$	729,230	$	177,808	$	551,422	$	729,230	$	139,711	$	589,519

Summary of Estimated Annual Amortization Expense Related to Intangible Assets

The following table outlines the estimated annual amortization expense related to intangible assets as of September 30, 2023:

		Estimated Amortization
Year Ending December 31,		(in thousands)
Remainder of 2023	$	12,744
2024		50,392
2025		50,294
2026		47,332
2027		46,803
2028 and Thereafter		343,857
	$	551,422

Summary of Goodwill and Intangible Assets Disclosure

At September 30, 2023 and December 31, 2022 the balances of goodwill, by segment, consisted of the following:

		Retail		Consumer Packaged Goods		Total
		(in thousands)
As of December 31, 2022	$	273,802	$	315,889	$	589,691
As of September 30, 2023	$	273,802	$	315,889	$	589,691

XML

Investments (Tables)

9 Months Ended

Sep. 30, 2023

Investments [Abstract]

Schedule Of Long Term Investments

The following table summarizes the changes in the Company’s investments during the nine months ended September 30, 2023 and year ending December 31, 2022:

		September 30, 2023		December 31, 2022
	(in thousands)
Beginning	$	74,169	$	94,902
Additions		3,700		5,444
Disposals		(331)		(3,571)
Fair value adjustment		(153)		(22,606)
Transfers and other		(50)		—
Ending	$	77,335	$	74,169

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Other information related to operating leases

Other information related to operating leases as of September 30, 2023 and December 31, 2022 were as follows:

	September 30, 2023	December 31, 2022
Weighted average remaining lease term (years)	11.98	11.64
Weighted average discount rate	12.41%	12.42%

Lessee, Operating Lease, Liability, Maturity

Maturities of lease liabilities for operating leases as of September 30, 2023 were as follows:

		Maturities of Lease Liability
Year Ending December 31,		Third Party		Related Party		Total
		(in thousands)
Remainder of 2023	$	10,669	$	143	$	10,812
2024		43,250		437		43,687
2025		41,114		343		41,457
2026		40,409		350		40,759
2027		40,793		357		41,150
2028 and Thereafter		358,013		1,728		359,741
Total Lease Payments		534,248		3,358		537,606
Less: Interest		(274,503)		(1,268)		(275,771)
Present Value of Lease Liability	$	259,745	$	2,090	$	261,835

XML

Notes Payable (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of Debt

At September 30, 2023 and December 31, 2022, notes payable consisted of the following:

		September 30, 2023		December 31, 2022
		(in thousands)
Charitable Contributions1	$	400	$	764
Private placement debt dated April 30, 20212		244,623		237,795
Mortgage notes3		53,518		37,109
Total notes payable		298,541		275,668
Less: current portion of notes payable		(1,466)		(1,037)
Notes payable, net of current portion	$	297,075	$	274,631

XML

Warrants (Tables)

9 Months Ended

Sep. 30, 2023

Class of Warrant or Right [Line Items]

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the number of warrants outstanding as of September 30, 2023 and December 31, 2022:

	Liability Classified							Equity Classified
	Number of Shares			Weighted Average Exercise Price (C$)		Weighted Average Remaining Contractual Life		Number of Shares			Weighted Average Exercise Price (USD)		Weighted Average Remaining Contractual Life
Balance as of December 31, 2022		1,997,208	C$		18.03		1.50		1,737,347	$		31.83		3.38
Balance as of September 30, 2023		1,997,208	C$		18.03		0.75		1,737,347	$		31.83		2.63

Liability Classified Warrant [Member]

Class of Warrant or Right [Line Items]

Schedule of Fair Value of Warrant Liability

The following table summarizes the fair value of the liability classified warrants at September 30, 2023 and December 31, 2022:

				Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		September 30, 2023		December 31, 2022		Change
				(in thousands)
Private Placement Financing Warrants Issued May 2019	C$19.39		1,606,533	$	1,820	$	3,125	$	(1,305	)
Modification Warrants Issued November 2019	C$12.04		316,947		1,434		1,139		295
Additional Modification Warrants Issued May 2020	C$14.03		73,728		332		256		76
Totals			1,997,208	$	3,586	$	4,520	$	(934	)

Schedule of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 13 - Fair Value Measurements for additional details):

	September 30,	December 31,
Significant Assumptions	2023	2022
Volatility	59.08% - 76.33%	70.44% - 78.21%
Remaining Term	0.64-1.64 years	1.39 - 2.39 years
Risk Free Rate	4.83%	3.82% - 4.07%

Equity Classified Warrant [Member]

Class of Warrant or Right [Line Items]

Schedule of Fair Value of Warrant Liability

The following table summarizes the carrying amounts of the Company's equity classified warrants at September 30, 2023 and December 31, 2022:

					Issuance Date Fair Value
			Warrants		September 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price		Outstanding		2023		2022
					(in thousands)
Mortgage Warrants Issued June 2020	$	9.10		35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$	32.68		1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$	30.02		243,303		2,616		2,616
Totals				1,737,347	$	25,056	$	25,056

Schedule of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability

The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date:

Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%

XML

Share Capital (Tables)

9 Months Ended

Sep. 30, 2023

Disclosure of Share Capital [Line Items]

Schedule of Common Stock Outstanding Roll Forward

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2023	206,991,275	38,531	251,690
Distribution of contingent consideration	1,614,871	—	—
Distribution of deferred shares	680,089	—	—
Issuance of shares upon exercise of options	365,521	—	—
Issuances of shares upon vesting of RSUs	390,676	—	—
Repurchase of Subordinate Voting Shares	(2,500,001)	—	—
Exchange of shares	2,500,000	—	(25,000)
As at September 30, 2023	210,042,431	38,531	226,690

Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]

The following table summarizes the activity during the nine months ended September 30, 2023:

Related Acquisition	As at December 31, 2022	Distributed Shares	Cancelled Shares	As at September 30, 2023
Liberty Compassion, Inc.	214,768	(214,768)	—	—
Dharma Pharmaceuticals, LLC	229,878	(229,878)	—	—
Mobley Pain Management and Wellness Center, LLC and Canwell Processing, LLC	264,760	(12,305)	(84,122)	168,333
GreenStar Herbals, Inc.	161,306	(161,306)	—	—
Maryland Health and Wellness Center, Inc.	61,832	(61,832)	—	—
LeafLine Industries, LLC	386,002	—	—	386,002
Total	1,318,546	(680,089)	(84,122)	554,335

Share-based Payment Arrangement, Option, Activity

Stock option activity is summarized as follows:

	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life
Balance as of December 31, 2022	9,577,947	$12.71	4.80
Granted	2,321,729	7.72	6.50
Exercised	(365,521)	7.34
Forfeited	(1,304,260)	12.25
Balance as of September 30, 2023	10,229,895	$11.82	4.60
Vested	5,341,985	$17.24
Exercisable as of September 30, 2023	3,566,406	$7.99	2.84

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2023 and the year ended December 31, 2022, using the following ranges of assumptions:

	September 30,	December 31,
	2023	2022
Risk-free interest rate	3.06% - 4%	1.18% - 3.54%
Expected dividend yield	0%	0%
Expected volatility	64%	60% - 64%
Expected option life	3.5 – 4.5 years	3 – 4.5 years

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Stock options expense	$	4,009	$	6,003	$	12,795	$	12,985
Restricted Stock Units		3,206		1,875		8,040		6,377
Total Stock Based Compensation Expense	$	7,215	$	7,878	$	20,835	$	19,362

Restricted Stock Units

Disclosure of Share Capital [Line Items]

Non-vested Restricted Stock Shares Activity

The following table summarizes the number of unvested RSU awards as of September 30, 2023 and December 31, 2022 and the changes during the nine months ended September 30, 2023:

	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2022	947,502	$	17.91
Granted	3,307,909		7.67
Forfeited	(365,542)		10.83
Vested	(390,676)		15.50
Unvested Shares at September 30, 2023	3,499,193	$	9.24

XML

Income Tax Expense (Tables)

9 Months Ended

Sep. 30, 2023

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

The following table summarizes the Company’s income tax expense and effective tax rates for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
Income before Income Taxes	$	45,333	$	43,117	$	127,829	$	167,005
Income Tax Expense		34,526		32,969		93,927		102,440
Effective Tax Rate		76.2%		76.5%		73.5%		61.3%

XML

Other Income (Expense) (Tables)

9 Months Ended

Sep. 30, 2023

Other Income and Expenses [Abstract]

Schedule of Other Nonoperating Income (Expense)

For the three and nine months ended September 30, 2023 and 2022 other income (expense) was comprised of the following:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	724	$	247	$	(410)	$	(17,368)
Fair value adjustments on equity method investments		—		—		—		14,119
Fair value adjustments on warrants issued		(1,329)		(1,896)		934		19,876
Earnings (loss) from equity method investments		(202)		(441)		(952)		(2,382)
Other		176		5		451		688
Total Other Income (Expense)	$	(631)	$	(2,085)	$	23	$	14,933

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2023

Disclosure Text Block Supplement [Abstract]

Fair Value Measurements, Recurring and Nonrecurring

The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:

		As of September 30, 2023
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	136,842	$	—	$	—	$	136,842
Investments		24,308		—		53,027		77,335
Contingent Consideration Payable		—		—		(32,789)		(32,789)
Warrant Liability		—		—		(3,586)		(3,586)
	$	161,150	$	—	$	16,652	$	177,802

		As of December 31, 2022
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	177,682	$	—	$	—	$	177,682
Investments		24,749		—		49,420		74,169
Contingent Consideration Payable		—		—		(41,943)		(41,943)
Warrant Liability		—		—		(4,520)		(4,520)
	$	202,431	$	—	$	2,957	$	205,388

XML

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Schedule of Revenues

The below table presents revenues by type for the three and nine months ended September 30, 2023 and 2022:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	205,441	$	199,632	$	582,363	$	564,951
Consumer Packaged Goods		150,425		127,676		412,096		368,692
Intersegment Eliminations		(80,468)		(66,114)		(218,137)		(175,538)
Total Revenues, Net of Discounts	$	275,398	$	261,194	$	776,322	$	758,105
Depreciation and Amortization
Retail	$	9,598	$	9,921	$	27,539	$	29,881
Consumer Packaged Goods		16,030		14,597		45,824		41,825
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	25,628	$	24,518	$	73,363	$	71,706
Income Taxes
Retail	$	18,551	$	18,589	$	50,890	$	58,460
Consumer Packaged Goods		15,975		14,380		43,037		43,980
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	34,526	$	32,969	$	93,927	$	102,440

XML

Overview and Basis of Presentation - Additional Information (Detail) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Number of Shares Outstanding, Diluted	240,289,959	237,804,799	239,827,112	237,872,595
Anti-dilutive stock options excluded from the computation of diluted earnings per share	2,349,064	2,052,822	3,198,625	2,192,896
Dilutive warrants	$ 0.05	$ 0.04	$ 0.14	$ 0.26
Stock Options Expense
Number of Shares Outstanding, Diluted			10,229,895	9,725,907
Weighted Average Number Diluted Shares Outstanding Adjustment	211,651	697,800	153,215	968,322
Restricted Stock Units
Number of Shares Outstanding, Diluted			3,499,193	952,753
Weighted Average Number Diluted Shares Outstanding Adjustment	618,525	57,128	1,425,045	226,564
Warrant
Number of Shares Outstanding, Diluted			3,734,555	3,835,278
Weighted Average Number Diluted Shares Outstanding Adjustment		46,998		131,631
Dilutive warrants	$ 0		$ 0

XML

Inventories - Summary of inventory (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Inventory [Line Items]
Raw Material	$ 1,120	$ 3,070
Packaging and Miscellaneous	10,756	9,847
Work in Process	45,072	57,287
Finished Goods	65,707	49,268
Reserve for Obsolete Inventory	(4,110)	(3,797)
Total Inventories	$ 118,545	$ 115,675

XML

Property and Equipment - Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total Property and Equipment	$ 716,834	$ 452,747
Less: Accumulated Depreciation	(113,507)	(80,702)
Property and Equipment, net	603,327	372,045
Property and Equipment, net	692,667	557,873
Land [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	33,725	29,106
Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	995	847
Assets Under Construction [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	55,615	156,722
Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	340,641	176,874
Equipment, Computers and Furniture [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	158,327	122,568
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	186,354	135,524
Capitalized Interest [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	$ 30,517	$ 16,934

XML

Property and Equipment - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disclosure of Property of Equipment [Line Items]
Depreciation expense	$ 12,885	$ 9,695	$ 35,266	$ 26,844
Cost of Sales [Member]
Disclosure of Property of Equipment [Line Items]
Depreciation expense	$ 8,298	$ 6,393	$ 23,348	$ 17,357

XML

Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands	Jul. 10, 2023	Feb. 25, 2022	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Business Acquisition [Line Items]
Business combination, contigent liability			$ 0		$ 200
Intangible Assets, Net			551,422	$ 589,519
Goodwill			589,691	589,691
Dharma Pharmaceuticals LLC [Member]
Business Acquisition [Line Items]
Business combination, contigent liability			$ 32,789	$ 41,943
Subordinate Voting Shares [Member]
Business Acquisition [Line Items]
Issuance of shares under business combinations and investments, value		$ 12,524
Subordinate Voting Shares [Member] | Dharma Pharmaceuticals LLC [Member]
Business Acquisition [Line Items]
Issuance of shares under business combinations and investments	792,424	822,447

XML

Intangible Assets And Goodwill - Summary Of Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 729,230	$ 729,230
Accumulated Amortization	177,808	139,711
Finite-Lived Intangible Assets, Net	551,422	589,519
Licenses And Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	660,716	660,716
Accumulated Amortization	146,739	113,800
Finite-Lived Intangible Assets, Net	513,977	546,916
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	41,511	41,511
Accumulated Amortization	12,655	10,486
Finite-Lived Intangible Assets, Net	28,856	31,025
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	24,438	24,438
Accumulated Amortization	16,054	13,435
Finite-Lived Intangible Assets, Net	8,384	11,003
Non Competition Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,565	2,565
Accumulated Amortization	2,360	1,990
Finite-Lived Intangible Assets, Net	$ 205	$ 575

XML

Intangible Assets And Goodwill - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Amortization	$ 12,743	$ 14,823	$ 38,097	$ 44,862
Weighted average amortization period			11 years 7 months 6 days

XML

Intangible Assets And Goodwill - Summary Of Estimated Annual Amortization Expense Related To Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
Remainder of 2023	$ 12,744
2024	50,392
2025	50,294
2026	47,332
2027	46,803
2028 and Thereafter	343,857
Finite-Lived Intangible Assets, Net	$ 551,422	$ 589,519

XML

Intangible Assets And Goodwill - Summary Of Goodwill And Intangible Assets Disclosure (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Goodwill [Line Items]
Goodwill	$ 589,691	$ 589,691
Retail Segment [Member]
Goodwill [Line Items]
Goodwill	273,802	273,802
Consumer Packaged Goods Segment [Member]
Goodwill [Line Items]
Goodwill	$ 315,889	$ 315,889

XML

Investments - Schedule Of Long Term Investments (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Longterm Investments [Line Items]
Beginning balance	$ 74,169	$ 94,902
Additions	3,700	5,444
Disposals	(331)	(3,571)
Fair value adjustments	(153)	(22,606)
Transfers out	(50)	0
Ending balance	$ 77,335	$ 74,169

XML

Investments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2019	Dec. 31, 2017
Investments [Line Items]
Unrealized gains and (losses) recognized on equity investments held	$ 660	$ 137	$ 350	$ 13,825
Fair value adjustments on equity method investments	0	0	0	(14,119)
Fair value gains (losses) on investments	775		153
Fair value of losses on equity method of investment	724		410
Investment in non convertible instrument	$ 22,214		$ 22,214		$ 22,214
Debt instrument interest rate	5.00%		5.00%		9.50%	7.00%	2.17%
Cannabis Companies [Member]
Investments [Line Items]
Equity interest, fair value disclosure	$ 77,335		$ 77,335		$ 74,169
Fair Value, Inputs, Level 1 [member]
Investments [Line Items]
Equity interest, fair value disclosure	2,094		2,094		2,535
Proceeds from sale of equity interest in privately held entity			31	2,393
Unrealized gains and (losses) recognized on equity investments held		124		14,169
Fair value adjustments on equity method investments	0	(418)	0	(236)
Fair Value, Inputs, Level 3 [member]
Investments [Line Items]
Equity interest, fair value disclosure	42,330		42,330		40,330
Fair value adjustments on equity method investments	0	0	0	(3,145)
Fair value gains (losses) on investments	0	(295)	0	182
Notes Receivable [Member]
Investments [Line Items]
Fair value gains (losses) on investments	$ 51		$ 257
Notes Receivable [Member] | Fair Value, Inputs, Level 1 [member]
Investments [Line Items]
Debt instrument interest rate	13.00%		13.00%
Notes Receivable [Member] | Fair Value, Inputs, Level 3 [member]
Investments [Line Items]
Fair value gains (losses) on investments	$ 51	$ 185	$ 257	$ 479
Investment in non convertible instrument	$ 10,697		$ 10,697		$ 9,090
Debt instrument interest rate	0.91%		0.91%
Minimum [Member] | Notes Receivable [Member] | Fair Value, Inputs, Level 3 [member]
Investments [Line Items]
Debt instrument, Term			9 months
Maximum [Member] | Notes Receivable [Member] | Fair Value, Inputs, Level 3 [member]
Investments [Line Items]
Debt instrument interest rate	10.00%		10.00%
Debt instrument, Term			5 years

XML

Leases - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense	$ 11,628	$ 11,884	$ 35,996	$ 31,906
Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense	$ 139	$ 296	$ 415	$ 886
Maximum [Member] | Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term	15 years		15 years
Minimum [Member] | Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term	7 years		7 years

XML

Leases - Schedule Of Other Information Related To Operating Leases (Detail)	Sep. 30, 2023	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Weighted average remaining lease term (years)	11 years 11 months 23 days	11 years 7 months 20 days
Weighted average discount rate	12.41%	12.42%

XML

Leases - Lessee Operating Lease Liability Maturity (Detail) $ in Thousands	Sep. 30, 2023 USD ($)
Lessee, Lease, Description [Line Items]
Remainder of 2023	$ 10,812
2024	43,687
2025	41,457
2026	40,759
2027	41,150
2028 and Thereafter	359,741
Total Lease Payments	537,606
Less: Interest	(275,771)
Present Value of Lease Liability	261,835
Third Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2023	10,669
2024	43,250
2025	41,114
2026	40,409
2027	40,793
2028 and Thereafter	358,013
Total Lease Payments	534,248
Less: Interest	(274,503)
Present Value of Lease Liability	259,745
RelatedParty [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2023	143
2024	437
2025	343
2026	350
2027	357
2028 and Thereafter	1,728
Total Lease Payments	3,358
Less: Interest	(1,268)
Present Value of Lease Liability	$ 2,090

XML

Notes Payable - Schedule of Debt (Detail) - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total notes payable		$ 298,541	$ 275,668
Less: current portion of notes payable		(1,466)	(1,037)
Notes payable, net of current portion		297,075	274,631
Acquired Debt [member]
Debt Instrument [Line Items]
Total notes payable	[1]	400	764
Private Placement Debt April 30, 2021 [Member]
Debt Instrument [Line Items]
Total notes payable	[2]	244,623	237,795
Mortgage Notes [Member]
Debt Instrument [Line Items]
Total notes payable	[3]	$ 53,518	$ 37,109

[1] 1 In connection with acquisitions completed in 2017 and 2019, the Company is required to make quarterly charitable contributions of $50 thousand through October 2024 and annual charitable contributions of $250 thousand through May 2024, respectively. The net present value of these required payments has been recorded as a liability with interest rates ranging between 2.17% - 7.00%.

[2] 2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in a total amount of $249,934 thousand with an interest rate of 7.00%, maturing on April 30, 2025. The April 30, 2021 Notes were issued at a discount, the carrying value of which was $5,311 thousand and $12,139 thousand as of September 30, 2023 and December 31, 2022, respectively.

[3] 3 Mortgage notes with an initial value of $55,017 thousand and $38,292 thousand, respectively, were issued by the Company in connection with various operating properties, and were recorded at such gross value as of September 30, 2023 and December 31, 2022. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00% and 9.50%. The mortgage notes were issued at a discount, the carrying value of which was $237 thousand and $437 thousand, respectively, and are presented net of principal payments of $1,262 thousand and $746 thousand as of September 30, 2023 and December 31, 2022, respectively.

XML

Notes Payable - Schedule of Debt (Parenthetical) (Detail) - USD ($) $ in Thousands		9 Months Ended	12 Months Ended
	Apr. 30, 2021	Sep. 30, 2023	Dec. 31, 2019	Dec. 31, 2017	Dec. 31, 2022
Debt Instrument [Line Items]
Charitable Contribution Quarterly Payment			$ 250	$ 50
Charitable Contribution, Date Of Last Payment			May 2024	October 2024
Debt Instrument Interest Rate		5.00%	7.00%	2.17%	9.50%
Private Placement Debt April 30, 2021 [Member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate	7.00%
Debt face value	$ 249,934
Debt Maturity Date	Apr. 30, 2025
Debt Instrument Carrying Amount		$ 5,311			$ 12,139
Mortgage Notes [Member]
Debt Instrument [Line Items]
Debt face value		$ 55,017			38,292
Debt Maturity Date		Jun. 05, 2035
Debt Instrument Carrying Amount		$ 237			437
Debt Instrument, Annual Principal Payment		$ 1,262			$ 746

XML

Notes Payable - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2023
Debt held by related parties	1.00%
Debt held by unrelated third-parties	99.00%

XML

Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Detail)	Sep. 30, 2023 $ / shares shares
Liability Classified Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance | shares	1,997,208
Number of Shares, Ending Balance | shares	1,997,208
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 18.03
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 18.03
Weighted Average Contractual Life, Beginning Balance	1 year 6 months
Weighted Average Contractual Life, Ending Balance	9 months
Equity Classified Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance | shares	1,737,347
Number of Shares, Ending Balance | shares	1,737,347
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 31.83
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 31.83
Weighted Average Contractual Life, Beginning Balance	3 years 4 months 17 days
Weighted Average Contractual Life, Ending Balance	2 years 7 months 17 days

XML

Warrants - Schedule of Fair Value of Warrant Liability (Detail) - Liability Classified Warrant [Member] - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,997,208	1,997,208
Warrant Liability	$ 3,586	$ 4,520
Change in Fair value of warrants liability	$ (934)
Private Placement Financing Warrants [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 19.39
Warrants Outstanding	1,606,533
Warrant Liability	$ 1,820	3,125
Change in Fair value of warrants liability	$ (1,305)
Modification Warrants [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 12.04
Warrants Outstanding	316,947
Warrant Liability	$ 1,434	1,139
Change in Fair value of warrants liability	$ 295
Additional Modification Warrants [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 14.03
Warrants Outstanding	73,728
Warrant Liability	$ 332	$ 256
Change in Fair value of warrants liability	$ 76

XML

Warrants - Additional Information (Detail) - Liability Classified Warrant [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Class of Warrant or Right [Line Items]
Change in Fair value of warrants liability			$ (934)
Other Income (Expense) [Member]
Class of Warrant or Right [Line Items]
Change in Fair value of warrants liability	$ 1,329	$ 1,896	$ 934	$ 19,876

XML

Warrants - Schedule of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability (Detail) - Liability Classified Warrant [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Volatility | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.5908	0.7044
Volatility | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.7633	0.7821
Remaining Term | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement Input term	7 months 20 days	1 year 4 months 20 days
Remaining Term | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement Input term	1 year 7 months 20 days	2 years 4 months 20 days
Risk Free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.0483
Risk Free Rate | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input		0.0382
Risk Free Rate | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input		0.0407

XML

Warrants - Fair Value of the Equity Classified Warrants (Detail) - Equity Classified Warrant [Member] - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,737,347	1,737,347
Warrant Liability	$ 25,056	$ 25,056
Mortgage Warrants [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 9.1
Warrants Outstanding	35,000
Warrant Liability	$ 181	181
Private Placement Refinancing Warrants [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 32.68
Warrants Outstanding	1,459,044
Warrant Liability	$ 22,259	22,259
Private Placement Refinancing Warrants1 [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 30.02
Warrants Outstanding	243,303
Warrant Liability	$ 2,616	$ 2,616

XML

Warrants - Schedule of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Equity Classified Warrants (Detail) - Equity Classified Warrant [Member]	9 Months Ended
	Sep. 30, 2023
Private Placement Refinancing Warrants1 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Oct. 15, 2021
Private Placement Refinancing Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Apr. 30, 2021
Mortgage Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Jun. 05, 2020
Volatility | Private Placement Refinancing Warrants1 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.73
Volatility | Private Placement Refinancing Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.73
Volatility | Mortgage Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.80
Remaining Term | Private Placement Refinancing Warrants1 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement Input term	4 years
Remaining Term | Private Placement Refinancing Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement Input term	4 years
Remaining Term | Mortgage Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement Input term	5 years
Risk Free Rate | Private Placement Refinancing Warrants1 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.0112
Risk Free Rate | Private Placement Refinancing Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.0074
Risk Free Rate | Mortgage Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.0037

XML

Share Capital - Schedule of Common Stock Outstanding Roll Forward (Detail)	9 Months Ended
	Sep. 30, 2023 shares
Share Capital [Member]
Class of Stock [Line Items]
Distribution of deferred shares	680,089
Subordinate Voting Shares [member]
Class of Stock [Line Items]
Beginning balance	206,991,275
Ending balance	210,042,431
Subordinate Voting Shares [member] | Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	206,991,275
Distribution of Contingent Consideration	1,614,871
Distribution of deferred shares	680,089
Issuance of shares upon exercise of options and warrants	365,521
Issuances of shares upon vesting of RSUs	390,676
Repurchase of Subordinate Voting Shares	(2,500,001)
Exchange of shares	2,500,000
Ending balance	210,042,431
Multiple Voting Shares [member]
Class of Stock [Line Items]
Beginning balance	38,531
Ending balance	38,531
Multiple Voting Shares [member] | Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	38,531
Ending balance	38,531
Super Voting Shares [member]
Class of Stock [Line Items]
Beginning balance	251,690
Ending balance	226,690
Super Voting Shares [member] | Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	251,690
Exchange of shares	(25,000)
Ending balance	226,690

XML

Share Capital - Distribution of Deferred Shares (Details) - Share Capital [Member]	9 Months Ended
	Sep. 30, 2023 shares
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	1,318,546
Distribution of deferred shares	(680,089)
Cancelled Share	(84,122)
Preferred Stock, Shares Outstanding, Ending Balance	554,335
Liberty Compassion [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	214,768
Distribution of deferred shares	(214,768)
Dharma Pharmaceuticals [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	229,878
Distribution of deferred shares	(229,878)
Mobley Pain Management and Wellness Center, LLC and Canwell Processing [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	264,760
Distribution of deferred shares	(12,305)
Cancelled Share	(84,122)
Preferred Stock, Shares Outstanding, Ending Balance	168,333
GreenStar Herbals [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	161,306
Distribution of deferred shares	(161,306)
Maryland Health and Wellness Center [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	61,832
Distribution of deferred shares	(61,832)
LeafLine Industrie [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding, Beginning Balance	386,002
Preferred Stock, Shares Outstanding, Ending Balance	386,002

XML

Share Capital - Share-based Payment Arrangement, Option, Activity (Detail) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Balance	9,577,947
Number of Share, Granted	2,321,729
Number of Shares, Exercised	(365,521)
Number of Shares, Forfeited	(1,304,260)
Number of Shares, Ending Balance	10,229,895	9,577,947
Number of Share, Vested	5,341,985
Number of Share, Exercisable	3,566,406
Weighted Average Exercise Price, Balance	$ 12.71
Weighted Average Exercise Price, Granted	7.72
Weighted Average Exercise Price, Exercised	7.34
Weighted Average Exercise Price, Forfeited	12.25
Weighted Average Exercise Price, Vested	17.24
Weighted Average Exercise Price, Ending Balance	11.82	$ 12.71
Weighted Average Exercise Price, Exercisable	$ 7.99
Weighted Average Contractual Life, Balance	4 years 7 months 6 days	4 years 9 months 18 days
Weighted Average Contractual Life, Granted	6 years 6 months
Weighted Average Contractual Life, Exercisable	2 years 10 months 2 days

XML

Share Capital - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Risk-free interest rate, Minumum	3.06%	1.18%
Risk-free interest rate, Maximum	4.00%	3.54%
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected volatility	64.00%	60.00%
Expected option life	3 years 6 months	3 years
Maximum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected volatility		64.00%
Expected option life	4 years 6 months	4 years 6 months

XML

Share Capital - Non-vested Restricted Stock Shares Activity (Detail)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Balance | shares	947,502
Number of Shares, Granted | shares	3,307,909
Number of Shares, Forfeited | shares	(365,542)
Number of Shares, Vested | shares	(390,676)
Number of Shares, Balance | shares	3,499,193
Weighted Average Grant Date Fair Value, Balance | $ / shares	$ 17.91
Weighted Average Grant Date Fair Value, Granted | $ / shares	7.67
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	10.83
Weighted Average Grant Date Fair Value, Vested | $ / shares	15.5
Weighted Average Grant Date Fair Value, Balance | $ / shares	$ 9.24

XML

Share Capital - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 7,215	$ 7,878	$ 20,835	$ 19,362
Stock options expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	4,009	6,003	12,795	12,985
Restricted Stock Units
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 3,206	$ 1,875	$ 8,040	$ 6,377

XML

Share Capital - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended	9 Months Ended
	Jul. 10, 2023	Feb. 25, 2022	Jun. 30, 2018	Sep. 30, 2023	Sep. 30, 2023	Sep. 05, 2023	Dec. 31, 2022	Sep. 30, 2022
Business combination, contigent liability				$ 0	$ 0			$ 200
Current liabilities				149,882	149,882		$ 146,571
Issuance of deferred shares				12,973	12,973		36,211
Dharma Pharmaceuticals LLC [Member]
Business combination, contigent liability				32,789	32,789		41,943
Current liabilities							$ 11,400
Restricted Stock Units (RSUs) [Member]
Cost Not yet Recognized, Amount				$ 45,048	$ 45,048
Cost Not yet Recognized, Period for Recognition					2 years 18 days
Multiple Voting Shares [Member]
Conversion Of Stock, Shares Converted				25,000
Common Stock, Shares, Outstanding				38,531	38,531		38,531
Multiple Voting Shares [Member] | Conversion Of Multiple Voting Shares [member]
Conversion Of Stock, Shares Converted					25,000
Conversion of Stock, Shares Issued				25,000
Voting Rights					100
Subordinate Voting Shares [Member]
Common Stock, Shares, Outstanding				210,042,431	210,042,431		206,991,275
Issuance of shares under business combinations and investments, value		$ 12,524
Subordinate Voting Shares [Member] | Dharma Pharmaceuticals LLC [Member]
Issuance of shares under business combinations and investments	792,424	822,447
Subordinate Voting Shares [Member] | Dharma Pharmaceuticals LLC [Member] | Maximum [Member]
Contingent consideration					$ 65,000
Subordinate Voting Shares [Member] | GTII Stock and Incentive Plan [Member]
Percentage of maximum number of shares issued under the plan			10.00%
Subordinate Voting Shares [Member] | Conversion Of Multiple Voting Shares [member]
Conversion Of Stock, Shares Converted					0
Conversion of Stock, Shares Issued				2,500,000	2,500,000
Shares Available For Conversion				3,853,100	3,853,100
Super Voting Shares [Member]
Conversion Of Stock, Shares Converted				25,000
Common Stock, Shares, Outstanding				226,690	226,690		251,690
Super Voting Shares [Member] | Conversion Of Super Voting Shares [member]
Conversion Of Stock, Shares Converted				25,000
Voting Rights					1,000
Shares Available For Conversion				22,669,000	22,669,000
Repurchase of Subordinate Voting Shares
Percentage of Stock Repurchase Program, Authorized						5.00%
Company Authorized Spend For Repurchase Program						$ 50,000
Company Repurchased Subordinate Voting Shares				2,500,000	2,500,000	10,486,951
Repurchased Average Price Per share					$ 9.96

XML

Share Capital - Summary Of Weighted Average Grant Date Fair Value And Total Fair Value Of RSUs Vested (Detail)	9 Months Ended
	Sep. 30, 2023 $ / shares
Weighted Average Grant Date Fair Value And Total Fair Value Of RSUs Vested [Line Items]
Weighted average grant date fair value (per share) of RSUs granted (CAD)	$ 7.67

XML

Income Tax Expense - Schedule of Components of Income Tax Expense (Benefit) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Income before Income Taxes	$ 45,333	$ 43,117	$ 127,829	$ 167,005
Income Tax Expense	$ 34,526	$ 32,969	$ 93,927	$ 102,440
Effective Tax Rate	76.20%	76.50%	73.50%	61.30%

XML

Income Tax Expense - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income tax paid	$ 80,398	$ 95,307

XML

Other Income (Expense) - Schedule of Other Nonoperating Income (Expense) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Fair value adjustments on equity investments	$ 724	$ 247	$ (410)	$ (17,368)
Fair value adjustments on equity method investments	0	0	0	14,119
Fair value adjustment on warrants issued	(1,329)	(1,896)	934	19,876
Earnings (loss) from equity method investments	(202)	(441)	(952)	(2,382)
Other	176	5	451	688
Total Other Income (Expense)	$ (631)	$ (2,085)	$ 23	$ 14,933

XML

Commitments and Contingencies - Additional Information (Detail) $ in Thousands	Sep. 30, 2023 USD ($)
Construction Commitments [member]
Disclosure of Commitments and Contingencies [Line Items]
Contractual obligation	$ 7,100

XML

Fair Value Measurements - Fair Value Measurements, Recurring and Nonrecurring (Detail) - Financial Instruments [Member] - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	$ 136,842	$ 177,682
Investments	77,335	74,169
Contingent Consideration Payable	(32,789)	(41,943)
Warrant Liability	(3,586)	(4,520)
Fair Value, Net Asset (Liability)	177,802	205,388
Fair Value, Inputs, Level 1 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	136,842	177,682
Investments	24,308	24,749
Contingent Consideration Payable	0	0
Warrant Liability	0	0
Fair Value, Net Asset (Liability)	161,150	202,431
Fair Value, Inputs, Level 2 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments	0	0
Contingent Consideration Payable	0	0
Warrant Liability	0	0
Fair Value, Net Asset (Liability)	0	0
Fair Value, Inputs, Level 3 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments	53,027	49,420
Contingent Consideration Payable	(32,789)	(41,943)
Warrant Liability	(3,586)	(4,520)
Fair Value, Net Asset (Liability)	$ 16,652	$ 2,957

XML

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Disclosure Text Block Supplement [Abstract]
Notes payable	$ 298,541	$ 275,668
Notes payable, current	$ 1,466	$ 1,037

XML

Segment Reporting - Schedule of Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Revenues, Net of Discounts	$ 275,398	$ 261,194	$ 776,322	$ 758,105
Depreciation and Amortization	25,628	24,518	73,363	71,706
Income Taxes	34,526	32,969	93,927	102,440
Operating Segments [Member] | Retail Segment [Member]
Segment Reporting Information [Line Items]
Revenues, Net of Discounts	205,441	199,632	582,363	564,951
Depreciation and Amortization	9,598	9,921	27,539	29,881
Income Taxes	18,551	18,589	50,890	58,460
Operating Segments [Member] | Consumer Packaged Goods Segment [Member]
Segment Reporting Information [Line Items]
Revenues, Net of Discounts	150,425	127,676	412,096	368,692
Depreciation and Amortization	16,030	14,597	45,824	41,825
Income Taxes	15,975	14,380	43,037	43,980
Operating Segments [Member] | Intersegment Eliminations and Corporate [Member]
Segment Reporting Information [Line Items]
Revenues, Net of Discounts	(80,468)	(66,114)	(218,137)	(175,538)
Depreciation and Amortization	0	0	0	0
Income Taxes	$ 0	$ 0	$ 0	$ 0

XML

Segment Reporting - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Goodwill	$ 589,691	$ 589,691
Intangible Assets Net	551,422	589,519
Consumer Packaged Goods Segment [Member]
Goodwill	315,889	315,889
Retail Segment [Member]
Goodwill	273,802	273,802
Operating Segments [Member] | Consumer Packaged Goods Segment [Member]
Goodwill	315,889	315,889
Intangible Assets Net	266,884	286,922
Operating Segments [Member] | Retail Segment [Member]
Goodwill	273,802	273,802
Intangible Assets Net	$ 284,538	$ 302,597